```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 3393 Reported in Senate (RS)]

<DOC>

                                                       Calendar No. 319
118th CONGRESS
  2d Session
                                S. 3393

 To reauthorize the SUPPORT for Patients and Communities Act, and for 
                            other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            December 4, 2023

  Mr. Sanders (for himself and Mr. Cassidy) introduced the following 
  bill; which was read twice and referred to the Committee on Health, 
                     Education, Labor, and Pensions

                            February 1, 2024

               Reported by Mr. Sanders, with an amendment
 [Strike out all after the enacting clause and insert the part printed 
                               in italic]

_______________________________________________________________________

                                 A BILL

 
 To reauthorize the SUPPORT for Patients and Communities Act, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

<DELETED>SECTION 1. SHORT TITLE; TABLE OF CONTENTS.</DELETED>

<DELETED>    (a) Short Title.--This Act may be cited as the ``SUPPORT 
for Patients and Communities Reauthorization Act''.</DELETED>
<DELETED>    (b) Table of Contents.--The table of contents for this Act 
is as follows:</DELETED>

<DELETED>Sec. 1. Short title; table of contents.
                      <DELETED>TITLE I--PREVENTION

<DELETED>Sec. 101. First responder training program.
<DELETED>Sec. 102. Surveillance and education regarding infections 
                            associated with illicit drug use and other 
                            risk factors.
<DELETED>Sec. 103. Preventing overdoses of controlled substances.
<DELETED>Sec. 104. Pilot program for public health laboratories to 
                            detect fentanyl and other synthetic 
                            opioids.
<DELETED>Sec. 105. Prenatal and postnatal health.
<DELETED>Sec. 106. Donald J. Cohen National Child Traumatic Stress 
                            Initiative.
<DELETED>Sec. 107. Surveillance and data collection for child, youth, 
                            and adult trauma.
<DELETED>Sec. 108. Preventing adverse childhood experiences.
<DELETED>Sec. 109. Clarification of use of funds for products used to 
                            prevent overdose deaths.
<DELETED>Sec. 110. Support for individuals and families impacted by 
                            fetal alcohol spectrum disorder.
<DELETED>Sec. 111. Promoting State choice in PDMP systems.
                      <DELETED>TITLE II--TREATMENT

<DELETED>Sec. 201. Residential treatment program for pregnant and 
                            postpartum women.
<DELETED>Sec. 202. Loan repayment program for substance use disorder 
                            treatment workforce.
<DELETED>Sec. 203. Regional centers of excellence in substance use 
                            disorder education.
<DELETED>Sec. 204. Mental and behavioral health education and training 
                            program.
<DELETED>Sec. 205. Grants to enhance access to substance use disorder 
                            treatment.
<DELETED>Sec. 206. Grants to improve trauma support services and mental 
                            health care for children and youth in 
                            educational settings.
<DELETED>Sec. 207. Development and dissemination of model training 
                            programs for substance use disorder patient 
                            records.
<DELETED>Sec. 208. Task force on best practices for trauma-informed 
                            identification, referral, and support.
<DELETED>Sec. 209. Program to support coordination and continuation of 
                            care for drug overdose patients.
<DELETED>Sec. 210. Regulations relating to special registration for 
                            telemedicine.
<DELETED>Sec. 211. Mental health parity.
<DELETED>Sec. 212. State guidance related to individuals with serious 
                            mental illness and children with serious 
                            emotional disturbance.
<DELETED>Sec. 213. Improving access to addiction medicine providers.
                      <DELETED>TITLE III--RECOVERY

<DELETED>Sec. 301. Youth prevention and recovery.
<DELETED>Sec. 302. Comprehensive opioid recovery centers.
<DELETED>Sec. 303. Building communities of recovery.
<DELETED>Sec. 304. Peer support technical assistance center.
<DELETED>Sec. 305. CAREER Act.
<DELETED>Sec. 306. Office of recovery.
                <DELETED>TITLE IV--TECHNICAL AMENDMENTS

<DELETED>Sec. 401. Delivery of a controlled substance by a pharmacy to 
                            an administering practitioner.
<DELETED>Sec. 402. Technical correction on controlled substances 
                            dispensing.
<DELETED>Sec. 403. Required training for prescribers of controlled 
                            substances.

                 <DELETED>TITLE I--PREVENTION</DELETED>

<DELETED>SEC. 101. FIRST RESPONDER TRAINING PROGRAM.</DELETED>

<DELETED>    Section 546 of the Public Health Service Act (42 U.S.C. 
290ee-1) is amended--</DELETED>
        <DELETED>    (1) in subsection (a), by striking ``tribes and 
        tribal'' and inserting ``Tribes and Tribal'';</DELETED>
        <DELETED>    (2) in subsections (a), (c), and (d)--</DELETED>
                <DELETED>    (A) by striking ``approved or cleared'' 
                each place it appears and inserting ``approved, 
                cleared, or otherwise legally marketed''; and</DELETED>
                <DELETED>    (B) by striking ``opioid'' each place it 
                appears;</DELETED>
        <DELETED>    (3) in subsection (f)--</DELETED>
                <DELETED>    (A) by striking ``approved or cleared'' 
                each place it appears and inserting ``approved, 
                cleared, or otherwise legally marketed'';</DELETED>
                <DELETED>    (B) in paragraph (1), by striking 
                ``opioid'';</DELETED>
                <DELETED>    (C) in paragraph (2)--</DELETED>
                        <DELETED>    (i) by striking ``opioid and 
                        heroin'' and inserting ``opioid, heroin, and 
                        other drug''; and</DELETED>
                        <DELETED>    (ii) by striking ``opioid 
                        overdose'' and inserting ``overdose''; 
                        and</DELETED>
                <DELETED>    (D) in paragraph (3), by striking ``opioid 
                and heroin''; and</DELETED>
        <DELETED>    (4) in subsection (h), by striking ``$36,000,000 
        for each of fiscal years 2019 through 2023'' and inserting 
        ``$56,000,000 for each of fiscal years 2024 through 
        2028''.</DELETED>

<DELETED>SEC. 102. SURVEILLANCE AND EDUCATION REGARDING INFECTIONS 
              ASSOCIATED WITH ILLICIT DRUG USE AND OTHER RISK 
              FACTORS.</DELETED>

<DELETED>    Section 317N(d) of the Public Health Service Act (42 
U.S.C. 247b-15(d)) is amended by striking ``2019 through 2023'' and 
inserting ``2024 through 2028''.</DELETED>

<DELETED>SEC. 103. PREVENTING OVERDOSES OF CONTROLLED 
              SUBSTANCES.</DELETED>

<DELETED>    Section 392A of the Public Health Service Act (42 U.S.C. 
280b-1) is amended--</DELETED>
        <DELETED>    (1) in subsection (a)--</DELETED>
                <DELETED>    (A) in paragraph (2)--</DELETED>
                        <DELETED>    (i) in subparagraph (C), by 
                        inserting ``and associated risks'' before the 
                        period at the end; and</DELETED>
                        <DELETED>    (ii) in subparagraph (D), by 
                        striking ``opioids'' and inserting ``substances 
                        causing overdose'';</DELETED>
                <DELETED>    (B) in paragraph (3)(A)--</DELETED>
                        <DELETED>    (i) by inserting ``identify 
                        substances causing overdose and'' after 
                        ``rapidly''; and</DELETED>
                        <DELETED>    (ii) by striking ``abuse, and 
                        overdoses'' and inserting ``overdoses, and 
                        associated risk factors'';</DELETED>
        <DELETED>    (2) in subsection (b)(2)--</DELETED>
                <DELETED>    (A) in subparagraph (B), by inserting ``, 
                and associated risk factors,'' after ``such 
                overdoses'';</DELETED>
                <DELETED>    (B) in subparagraph (C), by striking 
                ``coding'' and inserting ``monitoring and 
                identifying'';</DELETED>
                <DELETED>    (C) in subparagraph (E)--</DELETED>
                        <DELETED>    (i) by inserting a comma after 
                        ``public health laboratories''; and</DELETED>
                        <DELETED>    (ii) by inserting ``and other 
                        emerging substances related'' after 
                        ``analogues''; and</DELETED>
                <DELETED>    (D) in subparagraph (F,) by inserting 
                ``and associated risk factors'' after ``overdoses''; 
                and</DELETED>
        <DELETED>    (3) in subsection (e) by striking ``$496,000,000 
        for each of fiscal years 2019 through 2023'' and inserting 
        ``$505,579,000 for each of fiscal years 2024 through 
        2028''.</DELETED>

<DELETED>SEC. 104. PILOT PROGRAM FOR PUBLIC HEALTH LABORATORIES TO 
              DETECT FENTANYL AND OTHER SYNTHETIC OPIOIDS.</DELETED>

<DELETED>    Section 7011 of the SUPPORT for Patients and Communities 
Act (42 U.S.C. 247d-10 note) is amended by striking subsection 
(d).</DELETED>

<DELETED>SEC. 105. PRENATAL AND POSTNATAL HEALTH.</DELETED>

<DELETED>    Section 317L(d) of the Public Health Service Act (42 
U.S.C. 2476b-13(d)) is amended by striking ``2019 through 2023'' and 
inserting ``2024 through 2028''.</DELETED>

<DELETED>SEC. 106. DONALD J. COHEN NATIONAL CHILD TRAUMATIC STRESS 
              INITIATIVE.</DELETED>

<DELETED>    Section 582 of the Public Health Service Act (42 U.S.C. 
290hh-1) is amended--</DELETED>
        <DELETED>    (1) in the section heading, by striking ``violence 
        related stress'' and inserting ``traumatic events'';</DELETED>
        <DELETED>    (2) in subsection (a)--</DELETED>
                <DELETED>    (A) in the matter preceding paragraph (1), 
                by striking ``tribes and tribal'' and inserting 
                ``Tribes and Tribal''; and</DELETED>
                <DELETED>    (B) in paragraph (2), by inserting ``and 
                dissemination'' after ``the development'';</DELETED>
        <DELETED>    (3) in subsection (b), by inserting ``and 
        dissemination'' after ``the development'';</DELETED>
        <DELETED>    (4) in subsection (d)--</DELETED>
                <DELETED>    (A) by striking ``The NCTSI'' and 
                inserting the following:</DELETED>
        <DELETED>    ``(1) Coordinating center.--The NCTSI''; 
        and</DELETED>
                <DELETED>    (B) by adding at the end the 
                following:</DELETED>
        <DELETED>    ``(2) NCTSI grantees.--In carrying out subsection 
        (a)(2), NCTSI grantees shall develop trainings and other 
        resources, as applicable and appropriate, to support 
        implementation of the evidence-based practices developed and 
        disseminated under such subsection.'';</DELETED>
        <DELETED>    (5) in subsection (e)--</DELETED>
                <DELETED>    (A) by redesignating paragraphs (1) and 
                (2) as subparagraphs (A) and (B), respectively, and 
                adjusting the margins accordingly;</DELETED>
                <DELETED>    (B) in subparagraph (A), as so 
                redesignated, by inserting ``and implementation'' after 
                ``the dissemination'';</DELETED>
                <DELETED>    (C) by striking ``The NCTSI'' and 
                inserting the following:</DELETED>
        <DELETED>    ``(1) Coordinating center.--''; and</DELETED>
                <DELETED>    (D) by adding at the end the 
                following:</DELETED>
        <DELETED>    ``(2) NCTSI grantees.--NCTSI grantees shall, as 
        appropriate, collaborate with other such grantees, the NCTSI 
        coordinating center, and the Secretary in carrying out 
        subsections (a)(2) and (d)(2).'';</DELETED>
        <DELETED>    (6) by amending subsection (h) to read as 
        follows:</DELETED>
<DELETED>    ``(h) Application and Evaluation.--To be eligible to 
receive a grant, contract, or cooperative agreement under subsection 
(a), a public or nonprofit private entity or an Indian Tribe or Tribal 
organization shall submit to the Secretary an application at such time, 
in such manner, and containing such information and assurances as the 
Secretary may require, including--</DELETED>
        <DELETED>    ``(1) a plan for the rigorous evaluation of the 
        activities funded under the grant, contract or agreement, 
        including both process and outcomes evaluation, and the 
        submission of an evaluation at the end of the project period; 
        and</DELETED>
        <DELETED>    ``(2) a description of how such entity, Indian 
        Tribe, or Tribal organization will support efforts led by the 
        Secretary or the NCTSI coordinating center, as applicable, to 
        evaluate activities carried out under this section.''; 
        and</DELETED>
        <DELETED>    (7) in subsection (j), by striking ``, $63,887,000 
        for each of fiscal years 2019 through 2023'' and inserting 
        ``$93,887,000 for each of fiscal years 2024 and 2025, 
        $104,000,000 for fiscal year 2026, $110,000,000 for fiscal year 
        2027, and $112,661,000 for fiscal year 2028''.</DELETED>

<DELETED>SEC. 107. SURVEILLANCE AND DATA COLLECTION FOR CHILD, YOUTH, 
              AND ADULT TRAUMA.</DELETED>

<DELETED>    Section 7131(e) of the SUPPORT for Patients and 
Communities Act (42 U.S.C. 242t(e)) is amended by striking ``2019 
through 2023'' and inserting ``2024 through 2028''.</DELETED>

<DELETED>SEC. 108. PREVENTING ADVERSE CHILDHOOD EXPERIENCES.</DELETED>

<DELETED>    (a) Grant Program.--</DELETED>
        <DELETED>    (1) In general.--The Secretary of Health and Human 
        Services (referred to in this section as the ``Secretary''), 
        acting through the Director of the Centers for Disease Control 
        and Prevention, may award grants or cooperative agreements to 
        States, territories, Indian Tribes and Tribal organizations (as 
        such terms are defined in section 4 of the Indian Self-
        Determination and Education Assistance Act (25 U.S.C. 5304)), 
        and local governmental entities for purposes of carrying out 
        public health activities to improve health outcomes by 
        preventing or reducing adverse childhood experiences.</DELETED>
        <DELETED>    (2) Use of funds.--Recipients of an award under 
        this subsection may use such award to--</DELETED>
                <DELETED>    (A) identify, implement, and evaluate 
                evidence-based public health activities to prevent or 
                reduce adverse childhood experiences and improve health 
                outcomes;</DELETED>
                <DELETED>    (B) improve data collection and analysis 
                regarding the prevention and reduction of adverse 
                childhood experiences, including any such data 
                described in section 7131 of the SUPPORT for Patients 
                and Communities Act (42 U.S.C. 242t), to identify--
                </DELETED>
                        <DELETED>    (i) any geographic areas or 
                        populations within the jurisdiction of the 
                        recipient of an award that have 
                        disproportionately high rates of adverse 
                        childhood experiences;</DELETED>
                        <DELETED>    (ii) any types of adverse 
                        childhood experiences of high prevalence within 
                        such jurisdiction; and</DELETED>
                        <DELETED>    (iii) any short-term health 
                        outcomes and long-term health outcomes 
                        associated with adverse childhood experiences, 
                        including mental health and substance use 
                        disorders; and</DELETED>
                <DELETED>    (C) leverage such data and analysis to 
                inform the identification, implementation, and 
                evaluation of evidence-based public health activities 
                under subparagraph (A).</DELETED>
        <DELETED>    (3) Partnerships.--Recipients of an award under 
        this subsection may identify opportunities to establish, or 
        strengthen existing, partnerships with other relevant public 
        and private entities within such jurisdiction for purposes of 
        carrying out such award.</DELETED>
        <DELETED>    (4) Technical assistance.--The Secretary may 
        provide training and technical assistance to recipients of 
        awards under this subsection.</DELETED>
        <DELETED>    (5) Evaluation.--Not later than 2 years after the 
        date of enactment of this Act, and annually thereafter, the 
        Secretary shall report to the Committee on Health, Education, 
        Labor, and Pensions of the Senate and the Committee on Energy 
        and Commerce of the House of Representatives on the specific 
        activities supported through awards under this subsection, 
        including the effectiveness of such activities in preventing or 
        reducing adverse childhood experiences.</DELETED>
<DELETED>    (b) Research.--The Secretary may, as appropriate, conduct 
research to evaluate public health activities to address adverse 
childhood experiences.</DELETED>
<DELETED>    (c) Authorization of Appropriations.--To carry out this 
section, there is authorized to be appropriated $7,000,000 for each of 
fiscal years 2024 through 2028.</DELETED>

<DELETED>SEC. 109. CLARIFICATION OF USE OF FUNDS FOR PRODUCTS USED TO 
              PREVENT OVERDOSE DEATHS.</DELETED>

<DELETED>    The activities carried out pursuant to section 
1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 290ee-
3a(b)(4)(A)) may include facilitating access to products used to 
prevent overdose deaths by detecting the presence of one or more 
substances, to the extent the purchase and possession of such products 
is consistent with Federal and State law.</DELETED>

<DELETED>SEC. 110. SUPPORT FOR INDIVIDUALS AND FAMILIES IMPACTED BY 
              FETAL ALCOHOL SPECTRUM DISORDER.</DELETED>

<DELETED>    (a) In General.--Part O of title III of the Public Health 
Service Act (42 U.S.C. 280f et seq.) is amended--</DELETED>
        <DELETED>    (1) by amending the part heading to read as 
        follows: ``fetal alcohol spectrum disorders prevention and 
        services program'';</DELETED>
        <DELETED>    (2) in section 399H (42 U.S.C. 280f)--</DELETED>
                <DELETED>    (A) in the section heading, by striking 
                ``establishment of fetal alcohol syndrome prevention'' 
                and inserting ``fetal alcohol spectrum disorders 
                prevention, intervention,'';</DELETED>
                <DELETED>    (B) by striking ``Fetal Alcohol Syndrome 
                and Fetal Alcohol Effect'' each place it appears and 
                inserting ``FASD'';</DELETED>
                <DELETED>    (C) in subsection (a)--</DELETED>
                        <DELETED>    (i) by amending the heading to 
                        read as follows: ``In General'';</DELETED>
                        <DELETED>    (ii) in the matter preceding 
                        paragraph (1)--</DELETED>
                                <DELETED>    (I) by inserting ``or 
                                continue activities to support'' after 
                                ``shall establish'';</DELETED>
                                <DELETED>    (II) by striking ``FASD'' 
                                (as amended by subparagraph (B)) and 
                                inserting ``fetal alcohol spectrum 
                                disorders (referred to in this section 
                                as `FASD')'';</DELETED>
                                <DELETED>    (III) by striking 
                                ``prevention, intervention'' and 
                                inserting ``awareness, prevention, 
                                identification, intervention,''; 
                                and</DELETED>
                                <DELETED>    (IV) by striking ``that 
                                shall'' and inserting ``, which 
                                may'';</DELETED>
                        <DELETED>    (iii) in paragraph (1)--</DELETED>
                                <DELETED>    (I) in subparagraph (A)--
                                </DELETED>
                                        <DELETED>    (aa) by striking 
                                        ``medical schools'' and 
                                        inserting ``health professions 
                                        schools''; and</DELETED>
                                        <DELETED>    (bb) by inserting 
                                        ``infants,'' after ``provision 
                                        of services for''; 
                                        and</DELETED>
                                <DELETED>    (II) in subparagraph (D), 
                                by striking ``medical and mental'' and 
                                inserting ``agencies 
                                providing'';</DELETED>
                        <DELETED>    (iv) in paragraph (2)--</DELETED>
                                <DELETED>    (I) in the matter 
                                preceding subparagraph (A), by striking 
                                ``a prevention and diagnosis program to 
                                support clinical studies, 
                                demonstrations and other research as 
                                appropriate'' and inserting 
                                ``supporting and conducting research on 
                                FASD, as appropriate, 
                                including'';</DELETED>
                                <DELETED>    (II) in subparagraph (B)--
                                </DELETED>
                                        <DELETED>    (aa) by striking 
                                        ``prevention services and 
                                        interventions for pregnant, 
                                        alcohol-dependent women'' and 
                                        inserting ``culturally and 
                                        linguistically informed 
                                        evidence-based or practice-
                                        based interventions and 
                                        appropriate societal supports 
                                        for preventing prenatal alcohol 
                                        exposure, which may co-occur 
                                        with exposure to other 
                                        substances''; and</DELETED>
                                        <DELETED>    (bb) by striking 
                                        ``; and'' and inserting a 
                                        semicolon;</DELETED>
                        <DELETED>    (v) by striking paragraph (3) and 
                        inserting the following:</DELETED>
        <DELETED>    ``(3) integrating into surveillance practice an 
        evidence-based standard case definition for FASD and, in 
        collaboration with other Federal and outside partners, support 
        organizations of appropriate medical and mental health 
        professionals in their development and refinement of evidence-
        based clinical diagnostic guidelines and criteria for all FASD; 
        and</DELETED>
        <DELETED>    ``(4) building State and Tribal capacity for the 
        identification, treatment, and support of individuals with FASD 
        and their families, which may include--</DELETED>
                <DELETED>    ``(A) utilizing and adapting existing 
                Federal, State, or Tribal programs to include FASD 
                identification and FASD-informed support;</DELETED>
                <DELETED>    ``(B) developing and expanding screening 
                and diagnostic capacity for FASD;</DELETED>
                <DELETED>    ``(C) developing, implementing, and 
                evaluating targeted FASD-informed intervention programs 
                for FASD;</DELETED>
                <DELETED>    ``(D) increasing awareness of 
                FASD;</DELETED>
                <DELETED>    ``(E) providing training with respect to 
                FASD for professionals across relevant sectors; 
                and</DELETED>
                <DELETED>    ``(F) disseminating information about FASD 
                and support services to affected individuals and their 
                families.'';</DELETED>
                <DELETED>    (D) in subsection (b)--</DELETED>
                        <DELETED>    (i) by striking ``described in 
                        section 399I'';</DELETED>
                        <DELETED>    (ii) by striking ``The Secretary'' 
                        and inserting the following:</DELETED>
        <DELETED>    ``(1) In general.--The Secretary''; and</DELETED>
                        <DELETED>    (iii) by adding at the end the 
                        following:</DELETED>
        <DELETED>    ``(2) Eligible entities.--To be eligible to 
        receive a grant, or enter into a cooperative agreement or 
        contract, under this section, an entity shall--</DELETED>
                <DELETED>    ``(A) be a State, Indian Tribe or Tribal 
                organization, local government, scientific or academic 
                institution, or nonprofit organization; and</DELETED>
                <DELETED>    ``(B) prepare and submit to the Secretary 
                an application at such time, in such manner, and 
                containing such information as the Secretary may 
                require, including a description of the activities that 
                the entity intends to carry out using amounts received 
                under this section.</DELETED>
        <DELETED>    ``(3) Additional application contents.--The 
        Secretary may require that an entity using amounts from a 
        grant, cooperative agreement, or contract under this section 
        for an activity under subsection (a)(4) include in the 
        application for such amounts submitted under paragraph (2)(B)--
        </DELETED>
                <DELETED>    ``(A) a designation of an individual to 
                serve as a FASD State or Tribal coordinator of such 
                activity; and</DELETED>
                <DELETED>    ``(B) a description of an advisory 
                committee the entity will establish to provide guidance 
                for the entity on developing and implementing a 
                statewide or Tribal strategic plan to prevent FASD and 
                provide for the identification, treatment, and support 
                of individuals with FASD and their families.''; 
                and</DELETED>
                <DELETED>    (E) by striking subsections (c) and (d); 
                and</DELETED>
                <DELETED>    (F) by adding at the end the 
                following:</DELETED>
<DELETED>    ``(c) Definition of FASD-Informed.--For purposes of this 
section, the term `FASD-informed', with respect to support or an 
intervention program, means that such support or intervention program 
uses culturally and linguistically informed evidence-based or practice-
based interventions and appropriate societal supports to support an 
improved quality of life for an individual with FASD and the family of 
such individual.''; and</DELETED>
        <DELETED>    (3) by striking sections 399I, 399J, and 399K (42 
        U.S.C. 280f-1, 280f-2, 280f-3) and inserting the 
        following:</DELETED>

<DELETED>``SEC. 399I. FETAL ALCOHOL SPECTRUM DISORDERS CENTERS FOR 
              EXCELLENCE.</DELETED>

<DELETED>    ``(a) In General.--The Secretary shall, as appropriate, 
award grants, cooperative agreements, or contracts to public or 
nonprofit entities with demonstrated expertise in the prevention of, 
identification of, and intervention services with respect to, fetal 
alcohol spectrum disorders (referred to in this section as `FASD') and 
other related adverse conditions. Such awards shall be for the purposes 
of establishing Fetal Alcohol Spectrum Disorders Centers for Excellence 
to build local, Tribal, State, and national capacities to prevent the 
occurrence of FASD and other related adverse conditions, and to respond 
to the needs of individuals with FASD and their families by carrying 
out the programs described in subsection (b).</DELETED>
<DELETED>    ``(b) Programs.--An entity receiving an award under 
subsection (a) may use such award for the following purposes:</DELETED>
        <DELETED>    ``(1) Initiating or expanding diagnostic capacity 
        for FASD by increasing screening, assessment, identification, 
        and diagnosis.</DELETED>
        <DELETED>    ``(2) Developing and supporting public awareness 
        and outreach activities, including the use of a range of media 
        and public outreach, to raise public awareness of the risks 
        associated with alcohol consumption during pregnancy, with the 
        goals of reducing the prevalence of FASD and improving the 
        developmental, health (including mental health), and 
        educational outcomes of individuals with FASD and supporting 
        families caring for individuals with FASD.</DELETED>
        <DELETED>    ``(3) Acting as a clearinghouse for evidence-based 
        resources on FASD prevention, identification, and culturally 
        and linguistically informed best practices, including the 
        maintenance of a national data-based directory on FASD-specific 
        services in States, Indian Tribes, and local communities, and 
        disseminating ongoing research and developing resources on FASD 
        to help inform systems of care for individuals with FASD across 
        their lifespan.</DELETED>
        <DELETED>    ``(4) Increasing awareness and understanding of 
        efficacious, evidence-based screening tools and culturally and 
        linguistically appropriate evidence-based intervention services 
        and best practices, which may include by conducting national, 
        regional, State, Tribal, or peer cross-State webinars, 
        workshops, or conferences for training community leaders, 
        medical and mental health and substance use disorder 
        professionals, education and disability professionals, 
        families, law enforcement personnel, judges, individuals 
        working in financial assistance programs, social service 
        personnel, child welfare professionals, and other service 
        providers.</DELETED>
        <DELETED>    ``(5) Improving capacity for State, Tribal, and 
        local affiliates dedicated to FASD awareness, prevention, and 
        identification and family and individual support programs and 
        services.</DELETED>
        <DELETED>    ``(6) Providing technical assistance to recipients 
        of grants, cooperative agreements, or contracts under section 
        399H, as appropriate.</DELETED>
        <DELETED>    ``(7) Carrying out other functions, as 
        appropriate.</DELETED>
<DELETED>    ``(c) Application.--To be eligible for a grant, contract, 
or cooperative agreement under this section, an entity shall submit to 
the Secretary an application at such time, in such manner, and 
containing such information as the Secretary may require.</DELETED>
<DELETED>    ``(d) Subcontracting.--A public or private nonprofit 
entity may carry out the following activities required under this 
section through contracts or cooperative agreements with other public 
and private nonprofit entities with demonstrated expertise in 
FASD:</DELETED>
        <DELETED>    ``(1) Prevention activities.</DELETED>
        <DELETED>    ``(2) Screening and identification.</DELETED>
        <DELETED>    ``(3) Resource development and dissemination, 
        training and technical assistance, administration, and support 
        of FASD partner networks.</DELETED>
        <DELETED>    ``(4) Intervention services.</DELETED>

<DELETED>``SEC. 399J. AUTHORIZATION OF APPROPRIATIONS.</DELETED>

<DELETED>    ``There are authorized to be appropriated to carry out 
this part such sums as may be necessary for each of fiscal years 2024 
through 2028.''.</DELETED>
<DELETED>    (b) Report.--Not later than 4 years after the date of 
enactment of this Act, the Secretary of Health and Human Services shall 
submit to the Committee on Health, Education, Labor, and Pensions of 
the Senate and the Committee on Energy and Commerce of the House of 
Representatives a report on the efforts of the Department of Health and 
Human Services to advance public awareness on, and facilitate the 
identification of best practices related to, fetal alcohol spectrum 
disorders identification, prevention, treatment, and support.</DELETED>
<DELETED>    (c) Technical Amendment.--Section 519D of the Public 
Health Service Act (42 U.S.C. 290bb-25d) is repealed.</DELETED>

<DELETED>SEC. 111. PROMOTING STATE CHOICE IN PDMP SYSTEMS.</DELETED>

<DELETED>    Section 399O(h) of the Public Health Service Act (42 
U.S.C. 280g-3(h)) is amended by adding the following:</DELETED>
        <DELETED>    ``(5) Promoting state choice.--Nothing in this 
        section shall be construed to authorize the Secretary to 
        require States to use a specific vendor or a specific 
        interoperability connection other than to align with nationally 
        recognized, consensus-based open standards, such as in 
        accordance with sections 3001 and 3004.''.</DELETED>

                 <DELETED>TITLE II--TREATMENT</DELETED>

<DELETED>SEC. 201. RESIDENTIAL TREATMENT PROGRAM FOR PREGNANT AND 
              POSTPARTUM WOMEN.</DELETED>

<DELETED>    Section 508 of the Public Health Service Act (42 U.S.C. 
290bb-1) is amended--</DELETED>
        <DELETED>    (1) in subsection (d)(11)(C), by striking 
        ``providing health services'' and inserting ``providing health 
        care services'';</DELETED>
        <DELETED>    (2) in subsection (g)--</DELETED>
                <DELETED>    (A) by inserting ``a plan describing'' 
                after ``will provide''; and</DELETED>
                <DELETED>    (B) by adding at the end the following: 
                ``Such plan may include a description of how such 
                applicant will target outreach to women 
                disproportionately impacted by maternal substance use 
                disorder.''; and</DELETED>
        <DELETED>    (3) in subsection (s), by striking ``$29,931,000 
        for each of fiscal years 2019 through 2023'' and inserting 
        ``$38, 931,000 for each of fiscal years 2024 through 
        2028''.</DELETED>

<DELETED>SEC. 202. LOAN REPAYMENT PROGRAM FOR SUBSTANCE USE DISORDER 
              TREATMENT WORKFORCE.</DELETED>

<DELETED>    Section 781(j) of the Public Health Service Act (42 U.S.C. 
295h(j)) is amended by striking ``$25,000,000 for each of fiscal years 
2019 through 2023'' and inserting ``$50,000,000 for each of fiscal 
years 2024 through 2028''.</DELETED>

<DELETED>SEC. 203. REGIONAL CENTERS OF EXCELLENCE IN SUBSTANCE USE 
              DISORDER EDUCATION.</DELETED>

<DELETED>    Section 551 of the Public Health Service Act (42 U.S.C. 
290ee-6) is amended by striking subsection (f).</DELETED>

<DELETED>SEC. 204. MENTAL AND BEHAVIORAL HEALTH EDUCATION AND TRAINING 
              PROGRAM.</DELETED>

<DELETED>    Section 756(f) of the Public Health Service Act (42 U.S.C. 
294e-1(f)) is amended to read as follows:</DELETED>
<DELETED>    ``(f) Authorization of Appropriations.--To carry out this 
section, there is authorized to be appropriated the 
following:</DELETED>
        <DELETED>    ``(1) $50,000,000 for fiscal year 2024, to be 
        allocated as follows:</DELETED>
                <DELETED>    ``(A) For grants described in subsection 
                (a)(1), $15,000,000.</DELETED>
                <DELETED>    ``(B) For grants described in subsection 
                (a)(2), $15,000,000.</DELETED>
                <DELETED>    ``(C) For grants described in subsection 
                (a)(3), $10,000,000.</DELETED>
                <DELETED>    ``(D) For grants described in subsection 
                (a)(4), $10,000,000.</DELETED>
        <DELETED>    ``(2) $55,000,000 for fiscal year 2025, to be 
        allocated as follows:</DELETED>
                <DELETED>    ``(A) For grants described in subsection 
                (a)(1), $16,500,000.</DELETED>
                <DELETED>    ``(B) For grants described in subsection 
                (a)(2), $16,500,000.</DELETED>
                <DELETED>    ``(C) For grants described in subsection 
                (a)(3), $11,000,000.</DELETED>
                <DELETED>    ``(D) For grants described in subsection 
                (a)(4), $11,000,000.</DELETED>
        <DELETED>    ``(3) $60,000,000 for fiscal year 2026, to be 
        allocated as follows:</DELETED>
                <DELETED>    ``(A) For grants described in subsection 
                (a)(1), $18,000,000.</DELETED>
                <DELETED>    ``(B) For grants described in subsection 
                (a)(2), $18,000,000.</DELETED>
                <DELETED>    ``(C) For grants described in subsection 
                (a)(3), $12,000,000.</DELETED>
                <DELETED>    ``(D) For grants described in subsection 
                (a)(4), $12,000,000.</DELETED>
        <DELETED>    ``(4) $65,000,000 for fiscal year 2027, to be 
        allocated as follows:</DELETED>
                <DELETED>    ``(A) For grants described in subsection 
                (a)(1), $19,500,000.</DELETED>
                <DELETED>    ``(B) For grants described in subsection 
                (a)(2), $19,500,000.</DELETED>
                <DELETED>    ``(C) For grants described in subsection 
                (a)(3), $13,000,000.</DELETED>
                <DELETED>    ``(D) For grants described in subsection 
                (a)(4), $13,000,000.</DELETED>
        <DELETED>    ``(5) $75,000,000 for fiscal year 2028, to be 
        allocated as follows:</DELETED>
                <DELETED>    ``(A) For grants described in subsection 
                (a)(1), $22,500,000.</DELETED>
                <DELETED>    ``(B) For grants described in subsection 
                (a)(2), $22,500,000.</DELETED>
                <DELETED>    ``(C) For grants described in subsection 
                (a)(3), $15,000,000.</DELETED>
                <DELETED>    ``(D) For grants described in subsection 
                (a)(4), $15,000,000.''.</DELETED>

<DELETED>SEC. 205. GRANTS TO ENHANCE ACCESS TO SUBSTANCE USE DISORDER 
              TREATMENT.</DELETED>

<DELETED>    Section 3203 of the SUPPORT for Patients and Communities 
Act (21 U.S.C. 823 note) is amended--</DELETED>
        <DELETED>    (1) by striking subsection (b); and</DELETED>
        <DELETED>    (2) by striking ``In General--The Secretary'' and 
        inserting the following:</DELETED>
<DELETED>``The Secretary''.</DELETED>

<DELETED>SEC. 206. GRANTS TO IMPROVE TRAUMA SUPPORT SERVICES AND MENTAL 
              HEALTH CARE FOR CHILDREN AND YOUTH IN EDUCATIONAL 
              SETTINGS.</DELETED>

<DELETED>    Section 7134 of the SUPPORT for Patients and Communities 
Act (42 U.S.C. 280h-7) is amended--</DELETED>
        <DELETED>    (1) in subsection (a), by striking ``tribal'' and 
        inserting ``Tribal'';</DELETED>
        <DELETED>    (2) in subsection (c)--</DELETED>
                <DELETED>    (A) in paragraph (1), by inserting ``early 
                intervention,'' after ``screening,'';</DELETED>
                <DELETED>    (B) in paragraph (3)--</DELETED>
                        <DELETED>    (i) in the matter preceding 
                        subparagraph (A), by inserting ``other staff,'' 
                        after ``support personnel,''; and</DELETED>
                        <DELETED>    (ii) in subparagraph (A), by 
                        striking ``social and emotional learning'' and 
                        inserting ``developmentally appropriate 
                        practices''; and</DELETED>
                <DELETED>    (C) in paragraph (5), by inserting 
                ``reduce stigma associated with mental health care 
                and'' after ``efforts to'';</DELETED>
        <DELETED>    (3) in subsection (d)--</DELETED>
                <DELETED>    (A) in paragraph (4)--</DELETED>
                        <DELETED>    (i) in subparagraph (A), by 
                        striking ``; and'' and inserting a 
                        semicolon;</DELETED>
                        <DELETED>    (ii) in subparagraph (B)--
                        </DELETED>
                                <DELETED>    (I) by striking ``tribal 
                                organizations as appropriate, other 
                                school personnel'' and inserting 
                                ``Tribal organizations as appropriate, 
                                other staff''; and</DELETED>
                                <DELETED>    (II) by striking the 
                                period and inserting ``; and''; 
                                and</DELETED>
                        <DELETED>    (iii) by adding at the end the 
                        following:</DELETED>
                <DELETED>    ``(C) parents and guardians will be 
                informed of what trauma support services and mental 
                health care are available to their students and what 
                services and care their students receive, in accordance 
                with the parental consent requirements under subsection 
                (h)(2).''; and</DELETED>
                <DELETED>    (B) by adding at the end the 
                following:</DELETED>
        <DELETED>    ``(7) A plan for sustaining the program following 
        the end of the award period.'';</DELETED>
        <DELETED>    (4) in subsection (f)(1), by inserting ``, which 
        shall include a description of how the school obtains consent 
        from the student's parent or guardian for the provision of 
        trauma support services and mental health care'' after ``this 
        section'';</DELETED>
        <DELETED>    (5) in subsection (g), by striking ``tribal'' and 
        inserting ``Tribal'';</DELETED>
        <DELETED>    (6) in subsection (h)--</DELETED>
                <DELETED>    (A) in the subsection heading, by 
                inserting ``; Application of Certain Provisions'' after 
                ``Construction'';</DELETED>
                <DELETED>    (B) by striking ``tribal'' each place it 
                appears and inserting ``Tribal'';</DELETED>
                <DELETED>    (C) by redesignating paragraphs (1) and 
                (2) as subparagraphs (A) and (B), respectively, and 
                adjusting the margins accordingly;</DELETED>
                <DELETED>    (D) by striking ``Nothing in this 
                section'' and inserting the following:</DELETED>
        <DELETED>    ``(1) In general.--Nothing in this section''; 
        and</DELETED>
                <DELETED>    (E) by adding at the end the 
                following:</DELETED>
        <DELETED>    ``(2) Application of provisions.--</DELETED>
                <DELETED>    ``(A) Rules.--Section 4001 of the 
                Elementary and Secondary Education Act of 1965 (not 
                including the exception under subsection (a)(2)(B)(i) 
                of such section) shall apply to an entity receiving a 
                grant, contract, or cooperative agreement under this 
                section in the same manner as such section 4001 applies 
                to an entity receiving funding under title IV of such 
                Act.</DELETED>
                <DELETED>    ``(B) Privacy protections.--Any education 
                record of a student collected or maintained under 
                subsection (c)(4) shall have the protections required 
                for education records under section 444 of the General 
                Education Provisions Act.''.</DELETED>
        <DELETED>    (7) in subsection (k)--</DELETED>
                <DELETED>    (A) by redesignating paragraphs (5) 
                through (11) as paragraphs (6) through (12), 
                respectively; and</DELETED>
                <DELETED>    (B) by inserting after paragraph (4) the 
                following:</DELETED>
        <DELETED>    ``(5) Other staff.--The term `other staff' has the 
        meaning given such term in section 8101 of the Elementary and 
        Secondary Education Act of 1965.''; and</DELETED>
        <DELETED>    (8) in subsection (l), by striking ``2019 through 
        2023'' and inserting ``2024 through 2028''.</DELETED>

<DELETED>SEC. 207. DEVELOPMENT AND DISSEMINATION OF MODEL TRAINING 
              PROGRAMS FOR SUBSTANCE USE DISORDER PATIENT 
              RECORDS.</DELETED>

<DELETED>    Section 7053 of the SUPPORT for Patients and Communities 
Act (42 U.S.C. 290dd-2 note) is amended by striking subsection 
(e).</DELETED>

<DELETED>SEC. 208. TASK FORCE ON BEST PRACTICES FOR TRAUMA-INFORMED 
              IDENTIFICATION, REFERRAL, AND SUPPORT.</DELETED>

<DELETED>    Section 7132 of the SUPPORT for Patients and Communities 
Act (Public Law 115-271; 132 Stat. 4046) is amended--</DELETED>
        <DELETED>    (1) in subsection (b)(1)--</DELETED>
                <DELETED>    (A) by redesignating subparagraph (CC) as 
                subparagraph (DD); and</DELETED>
                <DELETED>    (B) by inserting after subparagraph (BB) 
                the following:</DELETED>
                <DELETED>    ``(CC) The Administration for Community 
                Living.'';</DELETED>
        <DELETED>    (2) in subsection (d)(1), in the matter preceding 
        subparagraph (A), by inserting ``, developmental disability 
        service providers'' before ``, individuals who are''; 
        and</DELETED>
        <DELETED>    (3) in subsection (i), by striking ``2023'' and 
        inserting ``2028''.</DELETED>

<DELETED>SEC. 209. PROGRAM TO SUPPORT COORDINATION AND CONTINUATION OF 
              CARE FOR DRUG OVERDOSE PATIENTS.</DELETED>

<DELETED>    Section 7081 of the SUPPORT for Patients and Communities 
Act (42 U.S.C. 290dd-4) is amended by striking subsection 
(f).</DELETED>

<DELETED>SEC. 210. REGULATIONS RELATING TO SPECIAL REGISTRATION FOR 
              TELEMEDICINE.</DELETED>

<DELETED>    Not later than 1 year after the date of enactment of this 
Act, the Attorney General, in consultation with the Secretary of Health 
and Human Services, shall promulgate the final regulations required 
under section 311(h)(2) of the Controlled Substances Act (21 U.S.C. 
831(h)(2)).</DELETED>

<DELETED>SEC. 211. MENTAL HEALTH PARITY.</DELETED>

<DELETED>    (a) In General.--Not later than January 1, 2025, the 
Inspector General of the Department of Labor, in coordination with the 
Inspector General of the Department of Health and Human Services, shall 
report to the Committee on Health, Education, Labor, and Pensions of 
the Senate and the Committee on Energy and Commerce and the Committee 
on Education and the Workforce of the House of Representatives on the 
following:</DELETED>
        <DELETED>    (1) The non-quantitative treatment limit (referred 
        to in this section as ``NQTL'') requirements with respect to 
        mental health and substance use disorder benefits under group 
        health plans and health insurance issuers under section 
        2726(a)(8) of the Public Health Service Act (42 U.S.C. 300gg-
        26(a)(8)), section 712(a)(8) of the Employee Retirement Income 
        Security Act of 1974 (29 U.S.C. 1185a(a)(8)), and section 
        9812(a)(8) of the Internal Revenue Code of 1986 (referred to in 
        this section as the ``NQTL comparative analysis 
        requirements''), and the requirements for the Secretary of 
        Health and Human Services, the Secretary of Labor, and the 
        Secretary of the Treasury to issue regulations, a compliance 
        program guide, and additional guidance documents and tools 
        providing guidance relating to mental health parity 
        requirements under section 2726(a) of the Public Health Service 
        Act (42 U.S.C. 300gg-26(a)), section 712(a) of the Employee 
        Retirement Income Security Act of 1974 (29 U.S.C. 1185a(a)), 
        and section 9812(a) of the Internal Revenue Code of 
        1986.</DELETED>
        <DELETED>    (2) With respect to the NQTL comparative analysis 
        requirements described in paragraph (1), an analysis of the 
        actions taken by the Secretary of Labor, the Secretary of the 
        Treasury, and the Secretary of Health and Human Services to 
        provide guidance to ensure that group health plans and health 
        insurance issuers can fully comply with mental health parity 
        requirements under section 2726 of the Public Health Service 
        Act (42 U.S.C. 300gg-26), section 712 of the Employee 
        Retirement Income Security Act of 1974 (29 U.S.C. 1185a), and 
        section 9812 of the Internal Revenue Code of 1986 and the NQTL 
        comparative analysis requirements described in paragraph (1), 
        including an analysis of--</DELETED>
                <DELETED>    (A) the extent to which the Secretary of 
                Labor, the Secretary of the Treasury, and the Secretary 
                of Health and Human Services have fulfilled the 
                requirement under section 203(b) of division BB of the 
                Consolidated Appropriations Act, 2021 (Public Law 116-
                260) to issue the specific guidance and regulations 
                pertaining to the requirements for group health plans 
                and health insurance issuers to demonstrate compliance 
                with the NQTL comparative analysis requirements; 
                and</DELETED>
                <DELETED>    (B) whether sufficient guidance and 
                examples from the Department of Labor and Department of 
                Health and Human Services, and the Department of the 
                Treasury exist to guide and assist group health plans 
                and health insurance issuers in complying with the 
                requirements to demonstrate compliance with mental 
                health parity NQTL comparative analysis requirements/
                under such sections 2726(a)(8), 712(a)(8), and 
                9812(a)(8).</DELETED>
        <DELETED>    (3) A review of the enforcement processes of the 
        Department of Labor and the Department of Health and Human 
        Services to evaluate the consistency of interpretation of the 
        requirements under section 2726(a)(8) of the Public Health 
        Service Act (42 U.S.C. 300gg-26(a)(8), section 712(a)(8) of the 
        Employee Retirement Income Security Act of 1974 (29 U.S.C. 
        1185a(a)(8)), and section 9812(a)(8) of the Internal Revenue 
        Code of 1986, in particular with respect to processes utilized 
        for enforcement, actions or inactions that constitute 
        noncompliance, and avoidance among the agencies of duplication 
        of enforcement, including an evaluation of compliance with 
        section 104 of the Health Insurance Portability and 
        Accountability Act of 1996 (Public Law 104-191).</DELETED>
        <DELETED>    (4) A review of the implementation, by the 
        Department of Labor, Department of Health and Human Services, 
        and Department of the Treasury, of mental health parity 
        requirements under section 2726 of the Public Health Service 
        Act (42 U.S.C. 300gg-26), section 712 of the Employee 
        Retirement Income Security Act of 1974 (29 U.S.C. 1185a), and 
        section 9812 of the Internal Revenue Code of 1986, including 
        all such requirements in effect through the enactment of the 
        Mental Health Parity Act of 1996 (Public Law 104-204), the Paul 
        Wellstone and Pete Domenici Mental Health Parity and Addiction 
        Equity Act of 2008 (Public Law 110-460), the 21st Century Cures 
        Act (Public Law 114-255), and the Consolidated Appropriations 
        Act, 2023 (Public Law 117-328) (including any amendments made 
        by such Acts), and including with respect to the timing of all 
        actions, delays of any actions, reasons for any such delays, 
        mandated requirements that were met only once but not each time 
        such requirements were mandated.</DELETED>
<DELETED>    (b) Definitions.--In this section, the terms ``group 
health plan'' and ``health insurance issuer'' have the meanings given 
such terms in section 733 of the Employee Retirement Income Security 
Act of 1974 (29 U.S.C. 1191b).</DELETED>

<DELETED>SEC. 212. STATE GUIDANCE RELATED TO INDIVIDUALS WITH SERIOUS 
              MENTAL ILLNESS AND CHILDREN WITH SERIOUS EMOTIONAL 
              DISTURBANCE.</DELETED>

<DELETED>    (a) Review of Use of Certain Funding.--Not later than 1 
year after the date of enactment of this Act, the Secretary of Health 
and Human Services, acting through the Assistant Secretary for Mental 
Health and Substance Use, shall conduct a review of the use by States 
of funds made available under the Community Mental Health Services 
Block Grant program under subpart I of part B of title XIX of the 
Public Health Service Act (42 U.S.C. 300x et seq.) for First Episode 
Psychosis activities. Such review shall consider the 
following:</DELETED>
        <DELETED>    (1) How the States use funds for evidence-based 
        treatments and services, such as coordinated specialty care, 
        according to the standard of care for individuals with early 
        serious mental illness, including the comprehensiveness of such 
        treatments to include all aspects of the recommended 
        intervention.</DELETED>
        <DELETED>    (2) How State mental health departments coordinate 
        with State Medicaid departments in the delivery of the 
        treatments and services described in paragraph (1).</DELETED>
        <DELETED>    (3) The percentage of the State funding under the 
        block grant program that is applied toward early serious mental 
        illness and funding in excess of, or under, 10 percent of the 
        amount of the grant, broken down by State.</DELETED>
        <DELETED>    (4) The percentage of funds expended by States 
        through such block grant program specifically on First Episode 
        Psychosis, to the extent such information is 
        available.</DELETED>
        <DELETED>    (5) How many individuals are served by the 
        expenditures described in paragraph (3)and (4), on a per-capita 
        basis.</DELETED>
        <DELETED>    (6) How the funds are used to reach underserved 
        populations, including rural populations and racial and ethnic 
        minority populations.</DELETED>
<DELETED>    (b) Report and Guidance.--</DELETED>
        <DELETED>    (1) Report.--Not later than 6 months after the 
        completion of the review under subsection (a), the Secretary of 
        Health and Human Services, acting through the Assistant 
        Secretary for Mental Health and Substance Use, shall submit to 
        the Committee on Appropriations, the Committee on Health, 
        Education, Labor, and Pensions, and the Committee on Finance of 
        the Senate and to the Committee on Appropriations and the 
        Committee on Energy and Commerce of the House of 
        Representatives a report on the findings made as a result of 
        the review conducted under subsection (a). Such report shall 
        include any recommendations with respect to any changes to the 
        Community Mental Health Services Block Grant program under 
        subpart I of part B of title XIX of the Public Health Service 
        Act (42 U.S.C. 300x et seq.), including the set aside required 
        for First Episode Psychosis, that would facilitate improved 
        outcomes for the targeted population involved.</DELETED>
        <DELETED>    (2) Guidance.--Not later than 1 year after the 
        date on which the report is submitted under paragraph (1), the 
        Secretary of Health and Human Services, acting through the 
        Assistant Secretary for Mental Health and Substance Use, shall 
        update the guidance provided to States under the Community 
        Mental Health Services Block Grant program based on the 
        findings and recommendations of the report.</DELETED>
<DELETED>    (c) Additional Guidance.--The Director of the National 
Institute of Mental Health shall coordinate with the Assistant 
Secretary for Mental Health and Substance Use in providing guidance to 
State grantees and provider subgrantees about research advances in the 
delivery of services for First Episode Psychosis under the Community 
Mental Health Services Block Grant program.</DELETED>
<DELETED>    (d) Guidance for States Relating to Health Care Services 
and Interventions for Individuals With Serious Mental Illness and 
Children With Serious Emotional Disturbance.--Not later than 2 years 
after the date of enactment of this Act, the Assistant Secretary for 
Mental Health and Substance Use, jointly with the Administrator of the 
Centers for Medicare & Medicaid Services and the Director of the 
National Institute of Mental Health--</DELETED>
        <DELETED>    (1) shall provide updated guidance to States 
        concerning the manner in which Federal funding provided to 
        States through programs administered by such agencies, 
        including the Community Mental Health Services Block Grant 
        program under subpart I of part B of title XIX of the Public 
        Health Service Act (42 U.S.C. 300x et seq.), may be coordinated 
        to provide evidence-based health care services such as 
        coordinated specialty care to individuals with serious mental 
        illness and serious emotional disturbance, and interventions 
        for individuals with early serious mental illness, including 
        First Episode Psychosis; and</DELETED>
        <DELETED>    (2) may streamline relevant State reporting 
        requirements if such streamlining would result in making it 
        easier for States to coordinate funding under the programs 
        described in paragraph (1) to improve treatments for 
        individuals with serious mental illness and serious emotional 
        disturbance.</DELETED>

<DELETED>SEC. 213. IMPROVING ACCESS TO ADDICTION MEDICINE 
              PROVIDERS.</DELETED>

<DELETED>    Section 597 of the Public Health Service Act (42 U.S.C. 
290ll) is amended--</DELETED>
        <DELETED>    (1) in subsection (a)(1), by inserting 
        ``diagnosis,'' after ``related to''; and</DELETED>
        <DELETED>    (2) in subsection (b), by inserting ``addiction 
        medicine,'' after ``psychiatry,''.</DELETED>

                 <DELETED>TITLE III--RECOVERY</DELETED>

<DELETED>SEC. 301. YOUTH PREVENTION AND RECOVERY.</DELETED>

<DELETED>    Section 7102(c) of the SUPPORT for Patients and 
Communities Act (42 U.S.C. 290bb-7a(c)) is amended--</DELETED>
        <DELETED>    (1) in paragraph (2)--</DELETED>
                <DELETED>    (A) in subparagraph (A)--</DELETED>
                        <DELETED>    (i) in clause (i)--</DELETED>
                                <DELETED>    (I) by inserting ``, or a 
                                consortia of local educational 
                                agencies,'' after ``a local educational 
                                agency''; and</DELETED>
                                <DELETED>    (II) by striking ``high 
                                schools'' and inserting ``secondary 
                                schools''; and</DELETED>
                        <DELETED>    (ii) in clause (vi), by striking 
                        ``tribe, or tribal'' and inserting ``Tribe, or 
                        Tribal'';</DELETED>
                <DELETED>    (B) by amending subparagraph (E) to read 
                as follows:</DELETED>
                <DELETED>    ``(E) Indian tribe; tribal organization.--
                The terms `Indian Tribe' and `Tribal organization' have 
                the meanings given such terms in section 4 of the 
                Indian Self-Determination and Education Assistance Act 
                (25 U.S.C. 5304).'';</DELETED>
                <DELETED>    (C) by redesignating subparagraph (K) as 
                subparagraph (L); and</DELETED>
                <DELETED>    (D) by inserting after subparagraph (J) 
                the following:</DELETED>
                <DELETED>    ``(K) Secondary school.--The term 
                `secondary school' has the meaning given such term in 
                section 8101 of the Elementary and Secondary Education 
                Act of 1965 (20 U.S.C. 7801).'';</DELETED>
        <DELETED>    (2) in paragraph (3)(A), in the matter preceding 
        clause (i)--</DELETED>
                <DELETED>    (A) by striking ``and abuse''; 
                and</DELETED>
                <DELETED>    (B) by inserting ``at increased risk for 
                substance misuse'' after ``specific 
                populations'';</DELETED>
        <DELETED>    (3) in paragraph (4)--</DELETED>
                <DELETED>    (A) in the matter preceding subparagraph 
                (A), by striking ``Indian tribes'' and inserting 
                ``Indian Tribes'';</DELETED>
                <DELETED>    (B) in subparagraph (A), by striking ``and 
                abuse''; and</DELETED>
                <DELETED>    (C) in subparagraph (B), by striking 
                ``peer mentoring'' and inserting ``peer-to-peer 
                support'';</DELETED>
        <DELETED>    (4) in paragraph (5), by striking ``tribal'' and 
        inserting ``Tribal'';</DELETED>
        <DELETED>    (5) in paragraph (6)(A)--</DELETED>
                <DELETED>    (A) in clause (iv), by striking ``; and'' 
                and inserting a semicolon; and</DELETED>
                <DELETED>    (B) by adding at the end the 
                following:</DELETED>
                        <DELETED>    ``(vi) a plan to sustain the 
                        activities carried out under the grant program, 
                        after the grant program has ended; 
                        and'';</DELETED>
        <DELETED>    (6) in paragraph (8), by striking ``2022'' and 
        inserting ``2027''; and</DELETED>
        <DELETED>    (7) by amending paragraph (9) to read as 
        follows:</DELETED>
        <DELETED>    ``(9) Authorization of appropriations.--To carry 
        out this subsection, there are authorized to be appropriated 
        $10,000,000 for fiscal year 2024, $12,000,000 for fiscal year 
        2025, $14,000,000 for fiscal year 2026, $16,000,000 for fiscal 
        year 2027, and $18,000,000 for fiscal year 2028.''.</DELETED>

<DELETED>SEC. 302. COMPREHENSIVE OPIOID RECOVERY CENTERS.</DELETED>

<DELETED>    Section 552 of the Public Health Service Act (42 U.S.C. 
290ee-7) is amended--</DELETED>
        <DELETED>    (1) in subsection (d)(2)--</DELETED>
                <DELETED>    (A) in the matter preceding subparagraph 
                (A), by striking ``and in such manner'' and inserting 
                ``, in such manner, and containing such information and 
                assurances''; and</DELETED>
                <DELETED>    (B) in subparagraph (A), by striking ``is 
                capable of coordinating with other entities to carry 
                out'' and inserting ``has the demonstrated capability 
                to carry out, through referral or contractual 
                arrangements'';</DELETED>
        <DELETED>    (2) in subsection (h)--</DELETED>
                <DELETED>    (A) by redesignating paragraphs (1) 
                through (4) as subparagraphs (A) through (D), 
                respectively, and adjusting the margins 
                accordingly;</DELETED>
                <DELETED>    (B) by striking ``With respect to'' and 
                inserting the following:</DELETED>
        <DELETED>    ``(1) In general.--With respect to''; 
        and</DELETED>
                <DELETED>    (C) by adding at the end the 
                following:</DELETED>
        <DELETED>    ``(2) Additional reporting for certain eligible 
        entities.--An entity carrying out activities described in 
        subsection (g) through referral or contractual arrangements 
        shall include in the submissions required under paragraph (1) 
        information related to the status of such referrals or 
        contractual arrangements, including an assessment of whether 
        such referrals or contractual arrangements are supporting the 
        ability of such entity to carry out such activities.''; 
        and</DELETED>
        <DELETED>    (3) in subsection (j), by striking ``2019 through 
        2023'' and inserting ``2024 through 2028''.</DELETED>

<DELETED>SEC. 303. BUILDING COMMUNITIES OF RECOVERY.</DELETED>

<DELETED>    Section 547(f) of the Public Health Service Act (42 U.S.C. 
290ee-2(f)) is amended by striking ``$5,000,000 for each of fiscal 
years 2019 through 2023'' and inserting ``$16,000,000 for each of 
fiscal years 2024 through 2028''.</DELETED>

<DELETED>SEC. 304. PEER SUPPORT TECHNICAL ASSISTANCE CENTER.</DELETED>

<DELETED>    Section 547A of the Public Health Service Act (42 U.S.C. 
290ee-2a) is amended--</DELETED>
        <DELETED>    (1) in subsection (b)(4), by striking ``building; 
        and'' and inserting the following: ``building, such as--
        </DELETED>
                <DELETED>    ``(A) professional development of peer 
                support specialists; and</DELETED>
                <DELETED>    ``(B) making recovery support services 
                available in nonclinical settings; and'';</DELETED>
        <DELETED>    (2) by redesignating subsections (d) and (e) as 
        subsections (e) and (f), respectively;</DELETED>
        <DELETED>    (3) by inserting after subsection (c) the 
        following:</DELETED>
<DELETED>    ``(d) Pilot Program.--</DELETED>
        <DELETED>    ``(1) In general.--The Secretary shall carry out a 
        pilot program to establish one regional technical assistance 
        center (referred to in this subsection as the `Regional 
        Center') to assist the Center in carrying out activities 
        described in subsection (b) within the geographic region of 
        such Regional Center in a manner that is tailored to the needs 
        of such region.</DELETED>
        <DELETED>    ``(2) Evaluation.--Not later than 4 years after 
        the date of enactment of the SUPPORT for Patients and 
        Communities Reauthorization Act, the Secretary shall evaluate 
        the activities of the Regional Center and submit to the 
        Committee on Health, Education, Labor, and Pensions of the 
        Senate and the Committee on Energy and Commerce of the House of 
        Representatives a report on the findings of such evaluation, 
        including--</DELETED>
                <DELETED>    ``(A) a description of the distinct roles 
                and responsibilities of the Regional Center and the 
                Center;</DELETED>
                <DELETED>    ``(B) available information relating to 
                the outcomes of the pilot program under this 
                subsection, such as any impact the Regional Center had 
                on the operations and efficiency of the Center relating 
                to requests for technical assistance and support within 
                the region of such Regional Center;</DELETED>
                <DELETED>    ``(C) a description of any gaps or areas 
                of duplication relating to the activities of the 
                Regional Center and the Center within such region; 
                and</DELETED>
                <DELETED>    ``(D) recommendations relating to the 
                modification, expansion, or termination of the pilot 
                program under this subsection.</DELETED>
        <DELETED>    ``(3) Termination.--This subsection shall 
        terminate on September 30, 2028.''; and</DELETED>
        <DELETED>    (4) in subsection (f), as so redesignated, by 
        striking ``$1,000,000 for each of fiscal years 2019 through 
        2023'' and inserting ``$2,000,000 for each of fiscal years 2024 
        through 2028''.</DELETED>

<DELETED>SEC. 305. CAREER ACT.</DELETED>

<DELETED>    (a) In General.--Section 7183 of the SUPPORT for Patients 
and Communities Act (42 U.S.C. 290ee-8) is amended--</DELETED>
        <DELETED>    (1) in the section heading, by inserting ``; 
        treatment, recovery, and workforce support grants'' after 
        ``career act'';</DELETED>
        <DELETED>    (2) in subsection (b), by inserting ``each'' 
        before ``for a period'';</DELETED>
        <DELETED>    (3) in subsection (c)--</DELETED>
                <DELETED>    (A) in paragraph (1), by striking ``the 
                rates described in paragraph (2)'' and inserting ``the 
                average rates for calendar years 2018 through 2022 
                described in paragraph (2)''; and</DELETED>
                <DELETED>    (B) by amending paragraph (2) to read as 
                follows:</DELETED>
        <DELETED>    ``(2) Rates.--The rates described in this 
        paragraph are the following:</DELETED>
                <DELETED>    ``(A) The highest age-adjusted average 
                rates of drug overdose deaths for calendar years 2018 
                through 2022 based on data from the Centers for Disease 
                Control and Prevention, including, if necessary, 
                provisional data for calendar year 2022.</DELETED>
                <DELETED>    ``(B) The highest average rates of 
                unemployment for calendar years 2018 through 2022 based 
                on data provided by the Bureau of Labor 
                Statistics.</DELETED>
                <DELETED>    ``(C) The lowest average labor force 
                participation rates for calendar years 2018 through 
                2022 based on data provided by the Bureau of Labor 
                Statistics.'';</DELETED>
        <DELETED>    (4) in subsection (g)--</DELETED>
                <DELETED>    (A) in each of paragraphs (1) and (3), by 
                redesignating subparagraphs (A) and (B) as clauses (i) 
                and (ii), respectively, and adjusting the margins 
                accordingly;</DELETED>
                <DELETED>    (B) by redesignating paragraphs (1) 
                through (3) as subparagraphs (A) through (C), 
                respectively, and adjusting the margins 
                accordingly;</DELETED>
                <DELETED>    (C) in the matter preceding subparagraph 
                (A) (as so redesignated), by striking ``An entity'' and 
                inserting the following:</DELETED>
        <DELETED>    ``(1) In general.--An entity''; and</DELETED>
                <DELETED>    (D) by adding at the end the 
                following:</DELETED>
        <DELETED>    ``(2) Transportation services.--An entity 
        receiving a grant under this section may use not more than 5 
        percent of the funds for providing transportation for 
        individuals to participate in an activity supported by a grant 
        under this section, which transportation shall be to or from a 
        place of work or a place where the individual is receiving 
        career and technical education or job training services or 
        receiving services directly linked to treatment of or recovery 
        from a substance use disorder.</DELETED>
        <DELETED>    ``(3) Limitation.--The Secretary may not require 
        an entity to, or give priority to an entity that plans to, use 
        the funds of a grant under this section for activities that are 
        not specified in this subsection.'';</DELETED>
        <DELETED>    (5) in subsection (i)(2), by inserting ``, which 
        shall include employment and earnings outcomes described in 
        subclauses (I) and (III) of section 116(b)(2)(A)(i) of the 
        Workforce Innovation and Opportunity Act (29 U.S.C. 
        3141(b)(2)(A)(i)) with respect to the participation of such 
        individuals with a substance use disorder in programs and 
        activities funded by the grant under this section'' after 
        ``subsection (g)'';</DELETED>
        <DELETED>    (6) in subsection (j)--</DELETED>
                <DELETED>    (A) in paragraph (1), by inserting ``for 
                grants awarded prior to the date of enactment of the 
                SUPPORT for Patients and Communities Reauthorization 
                Act'' after ``grant period under this section''; 
                and</DELETED>
                <DELETED>    (B) in paragraph (2)--</DELETED>
                        <DELETED>    (i) in the matter preceding 
                        subparagraph (A), by striking ``2 years after 
                        submitting the preliminary report required 
                        under paragraph (1)'' and inserting ``September 
                        30, 2028''; and</DELETED>
                        <DELETED>    (ii) in subparagraph (A), by 
                        striking ``(g)(3)'' and inserting 
                        ``(g)(1)(C)''; and</DELETED>
        <DELETED>    (7) in subsection (k), by striking ``$5,000,000 
        for each of fiscal years 2019 through 2023'' and inserting 
        ``$12,000,000 for each of fiscal years 2024 through 
        2028''.</DELETED>
<DELETED>    (b) Clerical Amendment.--The table of contents in section 
1(b) of the SUPPORT for Patients and Communities Act (Public Law 115-
271; 132 Stat. 3894) is amended by striking the item relating to 
section 7183 and inserting the following:</DELETED>

<DELETED>``Sec. 7183. CAREER Act; treatment, recovery, and workforce 
                            support grants.''.

<DELETED>SEC. 306. OFFICE OF RECOVERY.</DELETED>

<DELETED>    Part A of title V of the Public Health Service Act (42 
U.S.C. 290aa et seq.) is amended by inserting after section 501C (42 
U.S.C. 290aa-0b) the following:</DELETED>

<DELETED>``SEC. 501D. OFFICE OF RECOVERY.</DELETED>

<DELETED>    ``(a) In General.--There is established, within the 
Substance Abuse and Mental Health Services Administration, an Office of 
Recovery (referred to in this section as the `Office').</DELETED>
<DELETED>    ``(b) Responsibilities.--The Office shall, taking into 
account the perspectives of individuals with demonstrated experience in 
mental health or substance use disorder recovery--</DELETED>
        <DELETED>    ``(1) identify new and emerging challenges related 
        to the provision of recovery support services;</DELETED>
        <DELETED>    ``(2) support technical assistance, data analysis, 
        and evaluation functions in order to assist States, local 
        governmental entities, Indian Tribes, and Tribal organizations 
        in implementing and strengthening recovery support services, 
        consistent with the needs of such States, local governmental 
        entities, Indian Tribes, and Tribal organizations; 
        and</DELETED>
        <DELETED>    ``(3) ensure coordination of efforts to identify, 
        disseminate, and evaluate best practices related to--</DELETED>
                <DELETED>    ``(A) improving the capacity of, and 
                access to, recovery support services; and</DELETED>
                <DELETED>    ``(B) supporting the training, education, 
                professional development, and retention of peer support 
                specialists.</DELETED>
<DELETED>    ``(c) Report.--Not later than 4 years after the date of 
enactment of the SUPPORT for Patients and Communities Reauthorization 
Act, the Assistant Secretary for Mental Health and Substance Use shall 
submit to the Committee on Health, Education, Labor, and Pensions of 
the Senate and the Committee on Energy and Commerce of the House of 
Representatives a report on the activities conducted by the Office, 
including--</DELETED>
        <DELETED>    ``(1) a description of the specific roles and 
        responsibilities of the Office;</DELETED>
        <DELETED>    ``(2) a description of the relationship between 
        the Office and other relevant components or programs of the 
        Substance Abuse and Mental Health Services 
        Administration;</DELETED>
        <DELETED>    ``(3) the identification of any gaps in the 
        activities of the Substance Abuse and Mental Health Services 
        Administration or challenges in coordination between the Office 
        and such relevant components or programs of such agency; 
        and</DELETED>
        <DELETED>    ``(4) recommendations related to the continued 
        operations of the Office.</DELETED>
<DELETED>    ``(d) Sunset.--This section shall cease to have force or 
effect on September 30, 2028.''.</DELETED>

           <DELETED>TITLE IV--TECHNICAL AMENDMENTS</DELETED>

<DELETED>SEC. 401. DELIVERY OF A CONTROLLED SUBSTANCE BY A PHARMACY TO 
              AN ADMINISTERING PRACTITIONER.</DELETED>

<DELETED>    Section 309A(a) of the Controlled Substances Act (21 
U.S.C. 829a(a)) is amended by striking paragraph (2) and inserting the 
following:</DELETED>
        <DELETED>    ``(2) the controlled substance is a drug in 
        schedule III, IV, or V to be administered--</DELETED>
                <DELETED>    ``(A) by injection or implantation for the 
                purpose of maintenance or detoxification treatment; 
                or</DELETED>
                <DELETED>    ``(B) intranasally, subject to risk 
                evaluation and mitigation strategy pursuant to section 
                505-1 of the Federal Food, Drug, and Cosmetic Act (21 
                U.S.C. 355-1), with post-administration monitoring by a 
                health care professional;''.</DELETED>

<DELETED>SEC. 402. TECHNICAL CORRECTION ON CONTROLLED SUBSTANCES 
              DISPENSING.</DELETED>

<DELETED>    Effective as if included in the enactment of Public Law 
117-328--</DELETED>
        <DELETED>    (1) section 1252(a) of division FF of Public Law 
        117-328 (136 Stat. 5681) is amended, in the matter being 
        inserted into section 302(e) of the Controlled Substances Act, 
        by striking ``303(g)'' and inserting ``303(h)'';</DELETED>
        <DELETED>    (2) section 1262 of division FF of Public Law 117-
        328 (136 Stat. 5681) is amended--</DELETED>
                <DELETED>    (A) in subsection (a)--</DELETED>
                        <DELETED>    (i) in the matter preceding 
                        paragraph (1), by striking ``303(g)'' and 
                        inserting ``303(h)'';</DELETED>
                        <DELETED>    (ii) in the matter being stricken 
                        by subsection (a)(2), by striking ``(g)(1)'' 
                        and inserting ``(h)(1)''; and</DELETED>
                        <DELETED>    (iii) in the matter being inserted 
                        by subsection (a)(2), by striking ``(g) 
                        Practitioners'' and inserting ``(h) 
                        Practitioners''; and</DELETED>
                <DELETED>    (B) in subsection (b)--</DELETED>
                        <DELETED>    (i) in the matter being stricken 
                        by paragraph (1), by striking ``303(g)(1)'' and 
                        inserting ``303(h)(1)'';</DELETED>
                        <DELETED>    (ii) in the matter being inserted 
                        by paragraph (1), by striking ``303(g)'' and 
                        inserting ``303(h)'';</DELETED>
                        <DELETED>    (iii) in the matter being stricken 
                        by paragraph (2)(A), by striking ``303(g)(2)'' 
                        and inserting ``303(h)(2)'';</DELETED>
                        <DELETED>    (iv) in the matter being stricken 
                        by paragraph (3), by striking ``303(g)(2)(B)'' 
                        and inserting ``303(h)(2)(B)'';</DELETED>
                        <DELETED>    (v) in the matter being stricken 
                        by paragraph (5), by striking ``303(g)'' and 
                        inserting ``303(h)''; and</DELETED>
                        <DELETED>    (vi) in the matter being stricken 
                        by paragraph (6), by striking ``303(g)'' and 
                        inserting ``303(h)''; and</DELETED>
        <DELETED>    (3) section 1263(b) of division FF of Public Law 
        117-328 (136 Stat. 5685) is amended--</DELETED>
                <DELETED>    (A) by striking ``303(g)(2)'' and 
                inserting ``303(h)(2)''; and</DELETED>
                <DELETED>    (B) by striking ``(21 U.S.C. 823(g)(2))'' 
                and inserting ``(21 U.S.C. 823(h)(2))''.</DELETED>

<DELETED>SEC. 403. REQUIRED TRAINING FOR PRESCRIBERS OF CONTROLLED 
              SUBSTANCES.</DELETED>

<DELETED>    (a) In General.--Section 303 of the Controlled Substances 
Act (21 U.S.C. 823) is amended--</DELETED>
        <DELETED>    (1) by redesignating the second subsection 
        designated as subsection (l) as subsection (m); and</DELETED>
        <DELETED>    (2) in subsection (m)(1), as so redesignated--
        </DELETED>
                <DELETED>    (A) in subparagraph (A)--</DELETED>
                        <DELETED>    (i) In clause (iv)--</DELETED>
                                <DELETED>    (I) In subclause (I)--
                                </DELETED>
                                        <DELETED>    (aa) by inserting 
                                        ``the American Academy of 
                                        Family Physicians, the American 
                                        Podiatric Medical Association, 
                                        the Academy of General 
                                        Dentistry,'' before ``or any 
                                        other organization'';</DELETED>
                                        <DELETED>    (bb) by striking 
                                        ``or the Commission'' and 
                                        inserting ``the Commission''; 
                                        and</DELETED>
                                        <DELETED>    (cc) by inserting 
                                        ``, or the Council on Podiatric 
                                        Medical Education'' before the 
                                        semicolon at the end; 
                                        and</DELETED>
                                <DELETED>    (II) in subclause (III), 
                                by inserting ``or the American Academy 
                                of Family Physicians'' after 
                                ``Association''; and</DELETED>
                        <DELETED>    (ii) in clause (v), in the matter 
                        preceding subclause (I)--</DELETED>
                                <DELETED>    (I) by striking 
                                ``osteopathic medicine, dental 
                                surgery'' and inserting ``osteopathic 
                                medicine, podiatric medicine, dental 
                                surgery''; and</DELETED>
                                <DELETED>    (II) by striking ``or 
                                dental medicine curriculum'' and 
                                inserting ``or dental or podiatric 
                                medicine curriculum''; and</DELETED>
                <DELETED>    (B) in subparagraph (B)--</DELETED>
                        <DELETED>    (i) in clause (i), by inserting 
                        ``the American Pharmacists Association, the 
                        Accreditation Council on Pharmacy Education, 
                        the American Optometric Association, the 
                        American Psychiatric Nurses Association, the 
                        American Academy of Nursing, the American 
                        Academy of Family Physicians'' before ``, or 
                        any other organization''; and</DELETED>
                        <DELETED>    (ii) in clause (ii)--</DELETED>
                                <DELETED>    (I) by striking ``or 
                                accredited school'' and inserting ``, 
                                an accredited school''; and</DELETED>
                                <DELETED>    (II) by inserting ``, or 
                                an accredited school of pharmacy'' 
                                before ``in the United 
                                States''.</DELETED>
<DELETED>    (b) Effective Date.--The amendment made by subsection (a) 
shall take effect as if enacted on December 29, 2022.</DELETED>

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``SUPPORT for 
Patients and Communities Reauthorization Act''.
    (b) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title; table of contents.

                          TITLE I--PREVENTION

Sec. 101. First responder training program.
Sec. 102. Surveillance and education regarding infections associated 
                            with illicit drug use and other risk 
                            factors.
Sec. 103. Preventing overdoses of controlled substances.
Sec. 104. Pilot program for public health laboratories to detect 
                            fentanyl and other synthetic opioids.
Sec. 105. Prenatal and postnatal health.
Sec. 106. Donald J. Cohen National Child Traumatic Stress Initiative.
Sec. 107. Surveillance and data collection for child, youth, and adult 
                            trauma.
Sec. 108. Preventing adverse childhood experiences.
Sec. 109. Clarification of use of funds for products used to prevent 
                            overdose deaths.
Sec. 110. Support for individuals and families impacted by fetal 
                            alcohol spectrum disorder.
Sec. 111. Promoting State choice in PDMP systems.
Sec. 112. Protecting Suicide Prevention Lifeline from cybersecurity 
                            incidents.
Sec. 113. Bruce's Law.
Sec. 114. Guidance on at-home drug disposal systems.
Sec. 115. Review of opioid drugs and actions.
Sec. 116. Consideration of enriched enrollment randomized withdrawal 
                            methodology.
Sec. 117. Approval of new opioid analgesic drugs.
Sec. 118. Guidance on developing non-addictive medical products to 
                            treat pain or addiction.
Sec. 119. National Chronic Pain Information System.
Sec. 120. Requirements for electronic-prescribing for controlled 
                            substances under group health plans and 
                            group and individual health insurance 
                            coverage.

                          TITLE II--TREATMENT

Sec. 201. Residential treatment program for pregnant and postpartum 
                            women.
Sec. 202. Loan repayment program for substance use disorder treatment 
                            workforce.
Sec. 203. Regional centers of excellence in substance use disorder 
                            education.
Sec. 204. Mental and behavioral health education and training program.
Sec. 205. Grants to enhance access to substance use disorder treatment.
Sec. 206. Grants to improve trauma support services and mental health 
                            care for children and youth in educational 
                            settings.
Sec. 207. Development and dissemination of model training programs for 
                            substance use disorder patient records.
Sec. 208. Task force on best practices for trauma-informed 
                            identification, referral, and support.
Sec. 209. Program to support coordination and continuation of care for 
                            drug overdose patients.
Sec. 210. Regulations relating to special registration for 
                            telemedicine.
Sec. 211. Mental health parity.
Sec. 212. State guidance related to individuals with serious mental 
                            illness and children with serious emotional 
                            disturbance.
Sec. 213. Improving access to addiction medicine providers.
Sec. 214. Roundtable on using health information technology to improve 
                            mental health and substance use care 
                            outcomes.
Sec. 215. Peer-to-peer mental health support.
Sec. 216. Kid PROOF pilot program.

                          TITLE III--RECOVERY

Sec. 301. Youth prevention and recovery.
Sec. 302. Comprehensive opioid recovery centers.
Sec. 303. Building communities of recovery.
Sec. 304. Peer support technical assistance center.
Sec. 305. CAREER Act.
Sec. 306. Research and recommendations on criminal background check 
                            process for peer support specialists.
Sec. 307. Office of Recovery.
Sec. 308. Review of Grants.gov.

                     TITLE IV--TECHNICAL AMENDMENTS

Sec. 401. Delivery of a controlled substance by a pharmacy to an 
                            administering practitioner.
Sec. 402. Technical correction on controlled substances dispensing.
Sec. 403. Required training for prescribers of controlled substances.

                          TITLE I--PREVENTION

SEC. 101. FIRST RESPONDER TRAINING PROGRAM.

    Section 546 of the Public Health Service Act (42 U.S.C. 290ee-1) is 
amended--
            (1) in subsection (a), by striking ``tribes and tribal'' 
        and inserting ``Tribes and Tribal'';
            (2) in subsections (a), (c), and (d)--
                    (A) by striking ``approved or cleared'' each place 
                it appears and inserting ``approved, cleared, or 
                otherwise legally marketed''; and
                    (B) by striking ``opioid'' each place it appears;
            (3) in subsection (f)--
                    (A) by striking ``approved or cleared'' each place 
                it appears and inserting ``approved, cleared, or 
                otherwise legally marketed'';
                    (B) in paragraph (1), by striking ``opioid'';
                    (C) in paragraph (2)--
                            (i) by striking ``opioid and heroin'' and 
                        inserting ``opioid, heroin, and other drug''; 
                        and
                            (ii) by striking ``opioid overdose'' and 
                        inserting ``overdose''; and
                    (D) in paragraph (3), by striking ``opioid and 
                heroin''; and
            (4) in subsection (h), by striking ``$36,000,000 for each 
        of fiscal years 2019 through 2023'' and inserting ``$56,000,000 
        for each of fiscal years 2024 through 2028''.

SEC. 102. SURVEILLANCE AND EDUCATION REGARDING INFECTIONS ASSOCIATED 
              WITH ILLICIT DRUG USE AND OTHER RISK FACTORS.

    Section 317N(d) of the Public Health Service Act (42 U.S.C. 247b-
15(d)) is amended by striking ``2019 through 2023'' and inserting 
``2024 through 2028''.

SEC. 103. PREVENTING OVERDOSES OF CONTROLLED SUBSTANCES.

    Section 392A of the Public Health Service Act (42 U.S.C. 280b-1) is 
amended--
            (1) in subsection (a)--
                    (A) in paragraph (2)--
                            (i) in subparagraph (C), by inserting ``and 
                        associated risks'' before the period at the 
                        end; and
                            (ii) in subparagraph (D), by striking 
                        ``opioids'' and inserting ``substances causing 
                        overdose'';
                    (B) in paragraph (3)(A)--
                            (i) by inserting ``identify substances 
                        causing overdose and'' after ``rapidly''; and
                            (ii) by striking ``abuse, and overdoses'' 
                        and inserting ``overdoses, and associated risk 
                        factors'';
            (2) in subsection (b)(2)--
                    (A) in subparagraph (B), by inserting ``, and 
                associated risk factors,'' after ``such overdoses'';
                    (B) in subparagraph (C), by striking ``coding'' and 
                inserting ``monitoring and identifying'';
                    (C) in subparagraph (E)--
                            (i) by inserting a comma after ``public 
                        health laboratories''; and
                            (ii) by inserting ``and other emerging 
                        substances related'' after ``analogues''; and
                    (D) in subparagraph (F,) by inserting ``and 
                associated risk factors'' after ``overdoses''; and
            (3) in subsection (e), by striking ``$496,000,000 for each 
        of fiscal years 2019 through 2023'' and inserting 
        ``$505,579,000 for each of fiscal years 2024 through 2028''.

SEC. 104. PILOT PROGRAM FOR PUBLIC HEALTH LABORATORIES TO DETECT 
              FENTANYL AND OTHER SYNTHETIC OPIOIDS.

    Section 7011 of the SUPPORT for Patients and Communities Act (42 
U.S.C. 247d-10) is amended by striking subsection (d).

SEC. 105. PRENATAL AND POSTNATAL HEALTH.

    Section 317L(d) of the Public Health Service Act (42 U.S.C. 247b-
13(d)) is amended by striking ``2019 through 2023'' and inserting 
``2024 through 2028''.

SEC. 106. DONALD J. COHEN NATIONAL CHILD TRAUMATIC STRESS INITIATIVE.

    Section 582 of the Public Health Service Act (42 U.S.C. 290hh-1) is 
amended--
            (1) in the section heading, by striking ``violence related 
        stress'' and inserting ``traumatic events'';
            (2) in subsection (a)--
                    (A) in the matter preceding paragraph (1), by 
                striking ``tribes and tribal'' and inserting ``Tribes 
                and Tribal''; and
                    (B) in paragraph (2), by inserting ``and 
                dissemination'' after ``the development'';
            (3) in subsection (b), by inserting ``and dissemination'' 
        after ``the development'';
            (4) in subsection (d)--
                    (A) by striking ``The NCTSI'' and inserting the 
                following:
            ``(1) Coordinating center.--The NCTSI''; and
                    (B) by adding at the end the following:
            ``(2) NCTSI grantees.--In carrying out subsection (a)(2), 
        NCTSI grantees shall develop trainings and other resources, as 
        applicable and appropriate, to support implementation of the 
        evidence-based practices developed and disseminated under such 
        subsection.'';
            (5) in subsection (e)--
                    (A) by redesignating paragraphs (1) and (2) as 
                subparagraphs (A) and (B), respectively, and adjusting 
                the margins accordingly;
                    (B) in subparagraph (A), as so redesignated, by 
                inserting ``and implementation'' after ``the 
                dissemination'';
                    (C) by striking ``The NCTSI'' and inserting the 
                following:
            ``(1) Coordinating center.--''; and
                    (D) by adding at the end the following:
            ``(2) NCTSI grantees.--NCTSI grantees shall, as 
        appropriate, collaborate with other such grantees, the NCTSI 
        coordinating center, and the Secretary in carrying out 
        subsections (a)(2) and (d)(2).'';
            (6) by amending subsection (h) to read as follows:
    ``(h) Application and Evaluation.--To be eligible to receive a 
grant, contract, or cooperative agreement under subsection (a), a 
public or nonprofit private entity or an Indian Tribe or Tribal 
organization shall submit to the Secretary an application at such time, 
in such manner, and containing such information and assurances as the 
Secretary may require, including--
            ``(1) a plan for the rigorous evaluation of the activities 
        funded under the grant, contract, or agreement, including both 
        process and outcomes evaluation, and the submission of an 
        evaluation at the end of the project period; and
            ``(2) a description of how such entity, Indian Tribe, or 
        Tribal organization will support efforts led by the Secretary 
        or the NCTSI coordinating center, as applicable, to evaluate 
        activities carried out under this section.''; and
            (7) in subsection (j), by striking ``, $63,887,000 for each 
        of fiscal years 2019 through 2023'' and inserting ``$93,887,000 
        for each of fiscal years 2024 and 2025, $104,000,000 for fiscal 
        year 2026, $110,000,000 for fiscal year 2027, and $112,661,000 
        for fiscal year 2028''.

SEC. 107. SURVEILLANCE AND DATA COLLECTION FOR CHILD, YOUTH, AND ADULT 
              TRAUMA.

    Section 7131(e) of the SUPPORT for Patients and Communities Act (42 
U.S.C. 242t(e)) is amended by striking ``2019 through 2023'' and 
inserting ``2024 through 2028''.

SEC. 108. PREVENTING ADVERSE CHILDHOOD EXPERIENCES.

    (a) Grant Program.--
            (1) In general.--The Secretary of Health and Human Services 
        (referred to in this section as the ``Secretary''), acting 
        through the Director of the Centers for Disease Control and 
        Prevention, may award grants or cooperative agreements to 
        States, territories, Indian Tribes and Tribal organizations (as 
        such terms are defined in section 4 of the Indian Self-
        Determination and Education Assistance Act (25 U.S.C. 5304)), 
        and local governmental entities for purposes of carrying out 
        public health activities to improve health outcomes by 
        preventing or reducing adverse childhood experiences.
            (2) Use of funds.--Recipients of an award under this 
        subsection may use such award to--
                    (A) identify, implement, and evaluate evidence-
                based public health activities to prevent or reduce 
                adverse childhood experiences and improve health 
                outcomes;
                    (B) improve data collection and analysis regarding 
                the prevention and reduction of adverse childhood 
                experiences, including any such data described in 
                section 7131 of the SUPPORT for Patients and 
                Communities Act (42 U.S.C. 242t), to identify--
                            (i) any geographic areas or populations 
                        within the jurisdiction of the recipient of an 
                        award that have disproportionately high rates 
                        of adverse childhood experiences;
                            (ii) any types of adverse childhood 
                        experiences of high prevalence within such 
                        jurisdiction; and
                            (iii) any short-term health outcomes and 
                        long-term health outcomes associated with 
                        adverse childhood experiences, including mental 
                        health and substance use disorders; and
                    (C) leverage such data and analysis to inform the 
                identification, implementation, and evaluation of 
                evidence-based public health activities under 
                subparagraph (A).
            (3) Partnerships.--Recipients of an award under this 
        subsection may identify opportunities to establish, or 
        strengthen existing, partnerships with other relevant public 
        and private entities within such jurisdiction for purposes of 
        carrying out such award.
            (4) Technical assistance.--The Secretary may provide 
        training and technical assistance to recipients of awards under 
        this subsection.
            (5) Evaluation.--Not later than 2 years after the date of 
        enactment of this Act, and annually thereafter, the Secretary 
        shall report to the Committee on Health, Education, Labor, and 
        Pensions of the Senate and the Committee on Energy and Commerce 
        of the House of Representatives on the specific activities 
        supported through awards under this subsection, including the 
        effectiveness of such activities in preventing or reducing 
        adverse childhood experiences.
    (b) Research.--The Secretary may, as appropriate, conduct research 
to evaluate public health activities to address adverse childhood 
experiences.
    (c) Authorization of Appropriations.--To carry out this section, 
there is authorized to be appropriated $7,000,000 for each of fiscal 
years 2024 through 2028.

SEC. 109. CLARIFICATION OF USE OF FUNDS FOR PRODUCTS USED TO PREVENT 
              OVERDOSE DEATHS.

    The activities carried out pursuant to section 1003(b)(4)(A) of the 
21st Century Cures Act (42 U.S.C. 290ee-3a(b)(4)(A)) may include 
facilitating access to products used to prevent overdose deaths by 
detecting the presence of one or more substances, to the extent the 
purchase and possession of such products is consistent with Federal and 
State law.

SEC. 110. SUPPORT FOR INDIVIDUALS AND FAMILIES IMPACTED BY FETAL 
              ALCOHOL SPECTRUM DISORDER.

    (a) In General.--Part O of title III of the Public Health Service 
Act (42 U.S.C. 280f et seq.) is amended--
            (1) by amending the part heading to read as follows: 
        ``fetal alcohol spectrum disorders prevention and services 
        program'';
            (2) in section 399H (42 U.S.C. 280f)--
                    (A) in the section heading, by striking 
                ``establishment of fetal alcohol syndrome prevention'' 
                and inserting ``fetal alcohol spectrum disorders 
                prevention, intervention,'';
                    (B) by striking ``Fetal Alcohol Syndrome and Fetal 
                Alcohol Effect'' each place it appears and inserting 
                ``FASD'';
                    (C) in subsection (a)--
                            (i) by amending the heading to read as 
                        follows: ``In General'';
                            (ii) in the matter preceding paragraph 
                        (1)--
                                    (I) by inserting ``or continue 
                                activities to support'' after ``shall 
                                establish'';
                                    (II) by striking ``FASD'' (as 
                                amended by subparagraph (B)) and 
                                inserting ``fetal alcohol spectrum 
                                disorders (referred to in this section 
                                as `FASD')'';
                                    (III) by striking ``prevention, 
                                intervention'' and inserting 
                                ``awareness, prevention, 
                                identification, intervention,''; and
                                    (IV) by striking ``that shall'' and 
                                inserting ``, which may'';
                            (iii) in paragraph (1)--
                                    (I) in subparagraph (A)--
                                            (aa) by striking ``medical 
                                        schools'' and inserting 
                                        ``health professions schools''; 
                                        and
                                            (bb) by inserting 
                                        ``infants,'' after ``provision 
                                        of services for''; and
                                    (II) in subparagraph (D), by 
                                striking ``medical and mental'' and 
                                inserting ``agencies providing'';
                            (iv) in paragraph (2)--
                                    (I) in the matter preceding 
                                subparagraph (A), by striking ``a 
                                prevention and diagnosis program to 
                                support clinical studies, 
                                demonstrations and other research as 
                                appropriate'' and inserting 
                                ``supporting and conducting research on 
                                FASD, as appropriate, including'';
                                    (II) in subparagraph (B)--
                                            (aa) by striking 
                                        ``prevention services and 
                                        interventions for pregnant, 
                                        alcohol-dependent women'' and 
                                        inserting ``culturally and 
                                        linguistically appropriate 
                                        evidence-based or evidence-
                                        informed interventions and 
                                        appropriate societal supports 
                                        for preventing prenatal alcohol 
                                        exposure, which may co-occur 
                                        with exposure to other 
                                        substances''; and
                                            (bb) by striking ``; and'' 
                                        and inserting a semicolon;
                            (v) by striking paragraph (3) and inserting 
                        the following:
            ``(3) integrating into surveillance a case definition for 
        FASD and, in collaboration with other Federal and outside 
        partners, support organizations of appropriate medical and 
        mental health professionals in their development and refinement 
        of evidence-based clinical diagnostic guidelines and criteria 
        for all FASD; and
            ``(4) building State and Tribal capacity for the 
        identification, treatment, and support of individuals with FASD 
        and their families, which may include--
                    ``(A) utilizing and adapting existing Federal, 
                State, or Tribal programs to include FASD 
                identification and FASD-informed support;
                    ``(B) developing and expanding screening and 
                diagnostic capacity for FASD;
                    ``(C) developing, implementing, and evaluating 
                targeted FASD-informed intervention programs for FASD;
                    ``(D) increasing awareness of FASD;
                    ``(E) providing training with respect to FASD for 
                professionals across relevant sectors; and
                    ``(F) disseminating information about FASD and 
                support services to affected individuals and their 
                families.'';
                    (D) in subsection (b)--
                            (i) by striking ``described in section 
                        399I'';
                            (ii) by striking ``The Secretary'' and 
                        inserting the following:
            ``(1) In general.--The Secretary''; and
                            (iii) by adding at the end the following:
            ``(2) Eligible entities.--To be eligible to receive a 
        grant, or enter into a cooperative agreement or contract, under 
        this section, an entity shall--
                    ``(A) be a State, Indian Tribe or Tribal 
                organization, local government, scientific or academic 
                institution, or nonprofit organization; and
                    ``(B) prepare and submit to the Secretary an 
                application at such time, in such manner, and 
                containing such information as the Secretary may 
                require, including a description of the activities that 
                the entity intends to carry out using amounts received 
                under this section.
            ``(3) Additional application contents.--The Secretary may 
        require that an eligible entity include in the application 
        submitted under paragraph (2)(B)--
                    ``(A) a designation of an individual to serve as a 
                FASD State or Tribal coordinator of activities such 
                eligible entity proposes to carry out through a grant, 
                cooperative agreement, or contract under this section; 
                and
                    ``(B) a description of an advisory committee the 
                entity will establish to provide guidance for the 
                entity on developing and implementing a statewide or 
                Tribal strategic plan to prevent FASD and provide for 
                the identification, treatment, and support of 
                individuals with FASD and their families.''; and
                    (E) by striking subsections (c) and (d); and
                    (F) by adding at the end the following:
    ``(c) Definition of FASD-informed.--For purposes of this section, 
the term `FASD-informed', with respect to support or an intervention 
program, means that such support or intervention program uses 
culturally and linguistically informed evidence-based or practice-based 
interventions and appropriate societal supports to support an improved 
quality of life for an individual with FASD and the family of such 
individual.''; and
            (3) by striking sections 399I, 399J, and 399K (42 U.S.C. 
        280f-1, 280f-2, 280f-3) and inserting the following:

``SEC. 399I. FETAL ALCOHOL SPECTRUM DISORDERS CENTERS FOR EXCELLENCE.

    ``(a) In General.--The Secretary shall, as appropriate, award 
grants, cooperative agreements, or contracts to public or nonprofit 
private entities with demonstrated expertise in the prevention of, 
identification of, and intervention services with respect to, fetal 
alcohol spectrum disorders (referred to in this section as `FASD') and 
other related adverse conditions. Such awards shall be for the purposes 
of establishing Fetal Alcohol Spectrum Disorders Centers for Excellence 
to build local, Tribal, State, and nationwide capacities to prevent the 
occurrence of FASD and other related adverse conditions, and to respond 
to the needs of individuals with FASD and their families by carrying 
out the programs described in subsection (b).
    ``(b) Programs.--An entity receiving an award under subsection (a) 
may use such award for the following purposes:
            ``(1) Initiating or expanding diagnostic capacity for FASD 
        by increasing screening, assessment, identification, and 
        diagnosis.
            ``(2) Developing and supporting public awareness and 
        outreach activities, including the use of a range of media and 
        public outreach, to raise public awareness of the risks 
        associated with alcohol consumption during pregnancy, with the 
        goals of reducing the prevalence of FASD and improving the 
        developmental, health (including mental health), and 
        educational outcomes of individuals with FASD and supporting 
        families caring for individuals with FASD.
            ``(3) Acting as a clearinghouse for evidence-based 
        resources on FASD prevention, identification, and culturally 
        and linguistically appropriate best practices, including the 
        maintenance of a national data-based directory on FASD-specific 
        services in States, Indian Tribes, and local communities, and 
        disseminating ongoing research and developing resources on FASD 
        to help inform systems of care for individuals with FASD across 
        their lifespan.
            ``(4) Increasing awareness and understanding of 
        efficacious, evidence-based screening tools and culturally and 
        linguistically appropriate evidence-based intervention services 
        and best practices, which may include by conducting nationwide, 
        regional, State, Tribal, or peer cross-State webinars, 
        workshops, or conferences for training community leaders, 
        medical and mental health and substance use disorder 
        professionals, education and disability professionals, 
        families, law enforcement personnel, judges, individuals 
        working in financial assistance programs, social service 
        personnel, child welfare professionals, and other service 
        providers.
            ``(5) Improving capacity for State, Tribal, and local 
        affiliates dedicated to FASD awareness, prevention, and 
        identification and family and individual support programs and 
        services.
            ``(6) Providing technical assistance to recipients of 
        grants, cooperative agreements, or contracts under section 
        399H, as appropriate.
            ``(7) Carrying out other functions, as appropriate.
    ``(c) Application.--To be eligible for a grant, contract, or 
cooperative agreement under this section, an entity shall submit to the 
Secretary an application at such time, in such manner, and containing 
such information as the Secretary may require.
    ``(d) Subcontracting.--A public or private nonprofit entity may 
carry out the following activities required under this section through 
contracts or cooperative agreements with other public and private 
nonprofit entities with demonstrated expertise in FASD:
            ``(1) Prevention activities.
            ``(2) Screening and identification.
            ``(3) Resource development and dissemination, training and 
        technical assistance, administration, and support of FASD 
        partner networks.
            ``(4) Intervention and treatment services.

``SEC. 399J. AUTHORIZATION OF APPROPRIATIONS.

    ``There are authorized to be appropriated to carry out this part 
such sums as may be necessary for each of fiscal years 2024 through 
2028.''.
    (b) Report.--Not later than 4 years after the date of enactment of 
this Act, the Secretary of Health and Human Services shall submit to 
the Committee on Health, Education, Labor, and Pensions of the Senate 
and the Committee on Energy and Commerce of the House of 
Representatives a report on the efforts of the Department of Health and 
Human Services to advance public awareness of, and facilitate the 
identification of best practices related to, fetal alcohol spectrum 
disorders identification, prevention, treatment, and support.
    (c) Technical Amendment.--Section 519D of the Public Health Service 
Act (42 U.S.C. 290bb-25d) is repealed.

SEC. 111. PROMOTING STATE CHOICE IN PDMP SYSTEMS.

    Section 399O(h) of the Public Health Service Act (42 U.S.C. 280g-
3(h)) is amended by adding the following:
            ``(5) Promoting state choice.--Nothing in this section 
        shall be construed to authorize the Secretary to require States 
        to use a specific vendor or a specific interoperability 
        connection other than to align with nationally recognized, 
        consensus-based open standards, such as in accordance with the 
        application programming interface (API) requirements pursuant 
        to sections 3001 and 3004.''.

SEC. 112. PROTECTING SUICIDE PREVENTION LIFELINE FROM CYBERSECURITY 
              INCIDENTS.

    (a) National Suicide Prevention Lifeline Program.--Section 520E-
3(b) of the Public Health Service Act (42 U.S.C. 290bb-36c(b)) is 
amended--
            (1) in paragraph (4), by striking ``and'' at the end;
            (2) in paragraph (5), by striking the period at the end and 
        inserting ``; and''; and
            (3) by adding at the end the following:
            ``(6) taking such steps as may be necessary to ensure the 
        suicide prevention hotline is protected from cybersecurity 
        incidents and eliminates known cybersecurity 
        vulnerabilities.''.
    (b) Reporting.--Section 520E-3 of the Public Health Service Act (42 
U.S.C. 290bb-36c) is amended--
            (1) by redesignating subsection (f) as subsection (g); and
            (2) by inserting after subsection (e) the following:
    ``(f) Cybersecurity Reporting.--
            ``(1) Notification.--
                    ``(A) In general.--The program's network 
                administrator receiving Federal funding pursuant to 
                subsection (a) shall report to the Assistant Secretary, 
                in a manner that protects personal privacy, consistent 
                with applicable Federal and State privacy laws--
                            ``(i) any identified cybersecurity 
                        vulnerabilities to the program within a 
                        reasonable amount of time after identification 
                        of such a vulnerability; and
                            ``(ii) any identified cybersecurity 
                        incidents to the program within a reasonable 
                        amount of time after identification of such 
                        incident.
                    ``(B) Local and regional crisis centers.--Local and 
                regional crisis centers participating in the program 
                shall report to the program's network administrator 
                identified under subparagraph (A), in a manner that 
                protects personal privacy, consistent with applicable 
                Federal and State privacy laws--
                            ``(i) any identified cybersecurity 
                        vulnerabilities to the program within a 
                        reasonable amount of time after identification 
                        of such vulnerability; and
                            ``(ii) any identified cybersecurity 
                        incidents to the program within a reasonable 
                        amount of time after identification of such 
                        incident.
            ``(2) Notification.--If the program's network administrator 
        receiving funding pursuant to subsection (a) discovers, or is 
        informed by a local or regional crisis center pursuant to 
        paragraph (1)(B) of, a cybersecurity vulnerability or incident, 
        within a reasonable amount of time after such discovery or 
        receipt of information, such entity shall report the 
        vulnerability or incident to the Assistant Secretary.
            ``(3) Clarification.--
                    ``(A) Oversight.--
                            ``(i) Local and regional crisis centers.--
                        Except as provided in clause (ii), local and 
                        regional crisis centers participating in the 
                        program shall oversee all technology each 
                        center employs in the provision of services as 
                        a participant in the program.
                            ``(ii) Network administrator.--The 
                        program's network administrator receiving 
                        Federal funding pursuant to subsection (a) 
                        shall oversee the technology each crisis center 
                        employs in the provision of services as a 
                        participant in the program if such oversight 
                        responsibilities are established in the 
                        applicable network participation agreement.
                    ``(B) Supplement, not supplant.--The cybersecurity 
                incident reporting requirements under this subsection 
                shall supplement, and not supplant, cybersecurity 
                incident reporting requirements under other provisions 
                of applicable Federal law that are in effect on the 
                date of the enactment of the SUPPORT for Patients and 
                Communities Reauthorization Act.''.
    (c) Study.--Not later than 180 days after the date of the enactment 
of this Act, the Comptroller General of the United States shall--
            (1) conduct and complete a study that evaluates 
        cybersecurity risks and vulnerabilities associated with the 9-
        8-8 National Suicide Prevention Lifeline; and
            (2) submit a report of the findings of such study to the 
        Committee on Health, Education, Labor, and Pensions of the 
        Senate and the Committee on Energy and Commerce of the House of 
        Representatives.

SEC. 113. BRUCE'S LAW.

    (a) Youth Prevention and Recovery.--Section 7102(c) of the SUPPORT 
for Patients and Communities Act (42 U.S.C. 290bb-7a(c)) is amended--
            (1) in paragraph (3)(A)(i), by inserting ``, which may 
        include strategies to increase education and awareness of the 
        potency and dangers of synthetic opioids (including drugs 
        contaminated with fentanyl) and, as appropriate, other emerging 
        drug use or misuse issues'' before the semicolon; and
            (2) in paragraph (4)(A), by inserting ``and strategies to 
        increase education and awareness of the potency and dangers of 
        synthetic opioids (including drugs contaminated with fentanyl) 
        and, as appropriate, emerging drug use or misuse issues'' 
        before the semicolon.
    (b) Interdepartmental Substance Use Disorders Coordinating 
Committee.--Section 7022 of the SUPPORT for Patients and Communities 
Act (42 U.S.C. 290aa note) is amended--
            (1) by striking subsection (g) and inserting the following:
    ``(g) Working Groups.--
            ``(1) In general.--The Committee may establish working 
        groups for purposes of carrying out the duties described in 
        subsection (e). Any such working group shall be composed of 
        members of the Committee (or the designees of such members) and 
        may hold such meetings as are necessary to enable the working 
        group to carry out the duties delegated to the working group.
            ``(2) Additional federal interagency work group on fentanyl 
        contamination of illegal drugs.--
                    ``(A) Establishment.--The Secretary, acting through 
                the Committee, shall establish a Federal Interagency 
                Work Group on Fentanyl Contamination of Illegal Drugs 
                (referred to in this paragraph as the `Work Group'), 
                consisting of representatives from relevant Federal 
                departments and agencies on the Committee.
                    ``(B) Consultation.--The Work Group shall consult 
                with relevant stakeholders and subject matter experts, 
                including--
                            ``(i) State, Tribal, and local subject 
                        matter experts in reducing, preventing, and 
                        responding to drug overdose caused by fentanyl 
                        contamination of illicit drugs; and
                            ``(ii) family members of both adults and 
                        youth who have overdosed by fentanyl-
                        contaminated illicit drugs.
                    ``(C) Duties.--The Work Group shall--
                            ``(i) examine Federal efforts to reduce and 
                        prevent drug overdose by fentanyl-contaminated 
                        illicit drugs;
                            ``(ii) identify strategies to improve 
                        State, Tribal, and local responses to overdose 
                        by fentanyl-contaminated illicit drugs;
                            ``(iii) coordinate with the Secretary, as 
                        appropriate, in carrying out activities to 
                        raise public awareness of synthetic opioids and 
                        other emerging drug use and misuse issues;
                            ``(iv) make recommendations to Congress for 
                        improving Federal programs, including with 
                        respect to the coordination of efforts across 
                        such programs; and
                            ``(v) make recommendations for educating 
                        youth on the potency and dangers of drugs 
                        contaminated by fentanyl.
                    ``(D) Annual report to secretary.--The Work Group 
                shall annually prepare and submit to the Secretary, the 
                Committee on Health, Education, Labor, and Pensions of 
                the Senate, and the Committee on Education and the 
                Workforce of the House of Representatives, a report on 
                the activities carried out by the Work Group under 
                subparagraph (C), including recommendations to reduce 
                and prevent drug overdose by fentanyl contamination of 
                illegal drugs, in all populations, and specifically 
                among youth at risk for substance misuse.''; and
            (2) by striking subsection (i) and inserting the following:
    ``(i) Sunset.--The Committee shall terminate on September 30, 
2028.''.

SEC. 114. GUIDANCE ON AT-HOME DRUG DISPOSAL SYSTEMS.

    (a) In General.--Not later than one year after the date of 
enactment of this Act, the Secretary of Health and Human Services 
(referred to in this section as the ``Secretary''), in consultation 
with the Administrator of the Drug Enforcement Administration, shall 
publish guidance to facilitate the use of at-home safe disposal systems 
for applicable drugs, including for such at-home safe disposal systems 
that the Secretary may require as a part of a risk evaluation and 
mitigation strategy under section 505-1 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 355-1).
    (b) Contents.--The guidance under subsection (a) shall include--
            (1) recommended standards for effective at-home drug 
        disposal systems to meet applicable statutory or regulatory 
        requirements enforced by the Food and Drug Administration and, 
        as appropriate, the Drug Enforcement Administration;
            (2) recommended information to include as instructions for 
        use to disseminate with at-home drug disposal systems;
            (3) best practices and educational tools to support the use 
        of an at-home drug disposal system; and
            (4) recommended use of licensed health providers for the 
        dissemination of education, instruction, and at-home drug 
        disposal systems.

SEC. 115. REVIEW OF OPIOID DRUGS AND ACTIONS.

    Not later than one year after the date of enactment of this Act, 
the Secretary of Health and Human Services (referred to in this section 
as the ``Secretary'') shall publish on the website of the Food and Drug 
Administration (referred to in this section as the ``FDA'') a report 
that outlines a plan for completing a review of opioid analgesic drugs 
that are approved under section 505 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 355) that considers the public health effects 
of such opioid drugs as part of the benefit-risk assessment, and that 
addresses the activities of the FDA that relate to increasing the 
development of non-addictive medical products intended to treat pain or 
addiction. Such report shall include--
            (1) an opportunity for public input concerning the 
        regulation by the FDA of opioid analgesic drugs, including 
        scientific evidence that relates to conditions of use, safety, 
        or benefit-risk assessment (including consideration of the 
        public health effects) of such opioid drugs;
            (2) an update on the actions taken by the FDA to review the 
        effectiveness, safety, benefit-risk profile (which may include 
        public health effects), and use of approved opioid analgesic 
        drugs;
            (3) a timeline for an assessment of the potential need, as 
        appropriate, for labeling changes, revised or additional 
        postmarketing requirements, enforcement actions, or withdrawals 
        for opioid analgesic drugs;
            (4) an overview of the steps that the FDA has taken to 
        support the development and approval of non-addictive medical 
        products intended to treat pain or addiction, and actions 
        planned to further support the development and approval of such 
        products; and
            (5) an overview of the consideration by the FDA of clinical 
        trial methodologies for analgesic drugs, including the enriched 
        enrollment randomized withdrawal methodology, and the benefits 
        and drawbacks associated with different trial methodologies for 
        such drugs, incorporating any public input received under 
        paragraph (1).

SEC. 116. CONSIDERATION OF ENRICHED ENROLLMENT RANDOMIZED WITHDRAWAL 
              METHODOLOGY.

    (a) In General.--Not later than 2 years after the date of enactment 
of this Act, the Secretary of Health and Human Services (referred to in 
this section as the ``Secretary''), acting through the Commissioner of 
Food and Drugs, shall convene a meeting of the Anesthetic and Analgesic 
Drug Products Advisory Committee and the Drug Safety and Risk 
Management Advisory Committee of the Food and Drug Administration to 
review the use of the enriched enrollment randomized withdrawal 
methodology in clinical trials of opioid analgesic drugs and consider 
and make recommendations regarding the use of alternative clinical 
study methodologies. In conducting such review, the Secretary shall 
consider the report issued by the National Academy of Sciences under 
subsection (c).
    (b) Presentations.--If the Secretary allows for formal 
presentations in support of the use of the enriched enrollment 
randomized withdrawal methodology at the meeting described in 
subsection (a), the Secretary shall also allow for equal time at such 
meeting for presentations that are critical of such methodology.
    (c) Nas Study and Report.--The Secretary shall seek to enter into a 
contract with the National Academy of Sciences under which the National 
Academy--
            (1) conducts a study on the effectiveness of enriched 
        enrollment randomized withdrawal methodology in demonstrating 
        the efficacy of opioid analgesic drugs in treating chronic 
        pain; and
            (2) not later than 1 year after the date of enactment of 
        this Act, submits a report on such study to the Secretary.
    (d) Review of Opioid Analgesic Drugs.--In connection with the 
meeting described in subsection (a), the Anesthetic and Analgesic Drug 
Products Advisory Committee and the Drug Safety and Risk Management 
Advisory Committee of the Food and Drug Administration shall review the 
approved labeling and action package for approval (as described in 
subsection (l)(2) of section 505 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 355)), on all opioid analgesic drugs approved 
using enriched enrollment randomized withdrawal methodology under such 
section 505 as of the date of such meeting. The findings from such 
review shall be made publicly available on a website operated by the 
Secretary, acting through the Commissioner of Food and Drugs.
    (e) Definition of Opioid Analgesic Drug.--In this section, the term 
``opioid analgesic drug'' means a drug that has a labeled indication 
approved by the Food and Drug Administration to produce analgesia by 
acting upon the body's opioid receptors.

SEC. 117. APPROVAL OF NEW OPIOID ANALGESIC DRUGS.

    Section 505(c) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 355(c)) is amended by adding at the end the following:
            ``(6) Notwithstanding any other provision of this section, 
        in making a determination to approve or deny an application 
        submitted under subsection (b) for an opioid analgesic drug, 
        the Secretary may consider whether such drug provides a 
        substantial improvement, in terms of greater safety or greater 
        effectiveness, or major contribution to patient care, compared 
        to an approved opioid analgesic drug. For purposes of this 
        paragraph, the term `opioid analgesic drug' means a drug that 
        is approved under this section to produce analgesia by acting 
        upon the body's opioid receptors.''.

SEC. 118. GUIDANCE ON DEVELOPING NON-ADDICTIVE MEDICAL PRODUCTS TO 
              TREAT PAIN OR ADDICTION.

    Not later than 1 year after the date of enactment of this Act, the 
Secretary of Health and Human Services shall issue draft guidance under 
section 3001(b) of the SUPPORT for Patients and Communities Act (21 
U.S.C. 355 note) to address non-addictive analgesics for chronic pain, 
including the information required to be included in guidance documents 
under paragraphs (1) through (4) of such section 3001(b).

SEC. 119. NATIONAL CHRONIC PAIN INFORMATION SYSTEM.

    Part P of title III of the Public Health Service Act (42 U.S.C. 
280g et seq.) is amended by adding at the end the following:

``SEC. 399V-8. CHRONIC PAIN RESEARCH.

    ``(a) In General.--The Secretary, in consultation with the Director 
of the Centers for Disease Control and Prevention, the Director of the 
National Institutes of Health, and other agencies as the Secretary 
determines appropriate, shall--
            ``(1) utilize available Federal research data to clarify 
        the incidence and prevalence of chronic pain from any source, 
        including injuries, operations, and diseases and conditions;
            ``(2) identify gaps in the available research data and 
        collect deidentified population research data using medical 
        claims and survey data to fill gaps in available research data, 
        such as--
                    ``(A) incidence and prevalence of specific pain 
                conditions;
                    ``(B) demographics and other information, such as 
                age, race, ethnicity, gender, and geographic location;
                    ``(C) the incidence and prevalence of known chronic 
                pain conditions, as well as diseases and conditions 
                that include or lead to pain;
                    ``(D) risk factors that may be associated with 
                chronic pain conditions, such as genetic and 
                environmental risk factors and other information, as 
                appropriate;
                    ``(E) diagnosis and progression markers;
                    ``(F) both direct and indirect costs of illness;
                    ``(G) the epidemiology of the conditions;
                    ``(H) the detection, management, and treatment of 
                the conditions;
                    ``(I) the epidemiology, detection, management, and 
                treatment of frequent secondary or co-occurring 
                conditions, such as depression, anxiety, and substance 
                use disorders;
                    ``(J) the utilization of medical and social 
                services by patients with chronic pain conditions, 
                including the direct health care costs of pain 
                treatment, both traditional and alternative, and the 
                indirect costs (such as missed work, public and private 
                disability, and reduction in productivity); and
                    ``(K) the effectiveness of evidence-based treatment 
                approaches on chronic pain conditions;
            ``(3) develop, in collaboration with individuals and 
        organizations with appropriate chronic pain expertise, 
        including patients or patient advocates, epidemiologists, 
        representatives of national voluntary health associations, 
        health information technology experts, clinicians, and research 
        scientists, standard definitions and approaches for population 
        research on chronic pain to efficiently promote greater 
        comparability of data; and
            ``(4) disseminate, pursuant to the public webpage under 
        subsection (b), and, as appropriate, to the public and to other 
        Federal departments and agencies, any findings, developed 
        population research standards, and available Federal data 
        sources related to chronic pain.
    ``(b) Dissemination.--The Secretary, acting through the Director of 
the Centers for Disease Control and Prevention, shall establish a 
public webpage, to be known as the Chronic Pain Information Hub, that--
            ``(1) aggregates and summarizes available Federal data 
        sources, indicators, and peer-reviewed research related to 
        chronic pain;
            ``(2) includes an up-to-date summary of complete, ongoing, 
        and planned data collection and analysis related to chronic 
        pain that is conducted and supported by the Centers for Disease 
        Control and Prevention; and
            ``(3) translates research findings into clinical tools and 
        resources, recommendations for closing research gaps, and 
        recommendations for population research standards for 
        researchers, with recommendations updated annually to 
        incorporate research findings from the prior year.
    ``(c) Conflicts of Interest.--If an individual or organization that 
collaborates with the Secretary in carrying out subsection (a) receives 
a payment or other transfer of value of a type described in section 
1128G(a)(1)(A)(vi) of the Social Security Act from a manufacturer of a 
drug (including a biological product) or device that would be required 
to be disclosed pursuant to section 1128G(a)(1) of the Social Security 
Act, if the individual or organization were a covered recipient or if 
such disclosure were required upon request of or by designation on 
behalf of a covered recipient pursuant to such section, the individual 
or organization shall disclose to the Secretary information regarding 
such payment or other transfer of value. The Secretary shall make such 
disclosures publicly available.
    ``(d) Report.--Not later than 2 years after the date of the 
enactment of the SUPPORT for Patients and Communities Reauthorization 
Act, the Secretary shall submit a report to the Committee on Health, 
Education, Labor, and Pensions of the Senate and the Committee on 
Energy and Commerce of the House of Representatives concerning the 
implementation of this section. Such report shall include information 
on--
            ``(1) the development and maintenance of the Chronic Pain 
        Information Hub;
            ``(2) the information made available through the Chronic 
        Pain Information Hub;
            ``(3) the data gaps identified, and planned efforts to 
        address such gaps;
            ``(4) the process established for soliciting feedback from 
        collaborators; and
            ``(5) feedback received from collaborators.
    ``(e) Definition.--In this section, the term `chronic pain' means 
persistent or recurrent pain lasting longer than 3 months.
    ``(f) Authorization of Appropriations.--To carry out this section, 
there is authorized to be appropriated such sums as may be necessary 
for each of fiscal years 2024 through 2028.''.

SEC. 120. REQUIREMENTS FOR ELECTRONIC-PRESCRIBING FOR CONTROLLED 
              SUBSTANCES UNDER GROUP HEALTH PLANS AND GROUP AND 
              INDIVIDUAL HEALTH INSURANCE COVERAGE.

    (a) Public Health Service Act Amendment.--Section 2799A-7 of the 
Public Health Service Act (42 U.S.C. 300gg-117) is amended by adding at 
the end the following new subsection:
    ``(d) Requirements for Electronic-Prescribing for Controlled 
Substances.--
            ``(1) In general.--Except as provided pursuant to paragraph 
        (2), for plan years beginning on or after January 1, 2026, a 
        group health plan and a health insurance issuer offering group 
        or individual health insurance coverage, with respect to a 
        participating provider, as defined in section 2799-1(a)(3), 
        shall have in place policies, subject to paragraphs (4) and 
        (5), that require any prescription for a schedule II, III, IV, 
        or V controlled substance (as defined by section 202 of the 
        Controlled Substances Act) covered by the plan or coverage that 
        is transmitted by such a participating provider for such a 
        participant, beneficiary, or enrollee be electronically 
        transmitted consistent with standards established under 
        paragraph (3) of section 1860D-4(e) of the Social Security Act, 
        under an electronic prescription drug program that meets 
        requirements that are substantially similar (as jointly 
        determined by the Secretary, the Secretary of Labor, and the 
        Secretary of the Treasury) to the requirements of paragraph (2) 
        of such section 1860D-4(e).
            ``(2) Exception for certain circumstances.--The Secretary, 
        the Secretary of Labor, and the Secretary of the Treasury shall 
        jointly, through rulemaking, specify circumstances and 
        processes by which the requirement under paragraph (1) may be 
        waived, with respect to a schedule II, III, IV, or V controlled 
        substance that is a prescription drug covered by a group health 
        plan or group or individual health insurance coverage offered 
        by a health insurance issuer, including in the case of--
                    ``(A) a prescription issued when the participating 
                provider and dispensing pharmacy are the same entity;
                    ``(B) a prescription issued that cannot be 
                transmitted electronically under the most recently 
                implemented version of the National Council for 
                Prescription Drug Programs SCRIPT Standard;
                    ``(C) a prescription issued by a participating 
                provider who received a waiver (which may include a 
                waiver obtained pursuant to section 1860D-
                4(e)(7)(B)(iii) of the Social Security Act) or a 
                renewal thereof for a period of time as determined by 
                the Secretary, the Secretary of Labor, and the 
                Secretary of the Treasury, not to exceed one year, from 
                the requirement to use electronic prescribing due to 
                demonstrated economic hardship, technological 
                limitations that are not reasonably within the control 
                of the participating provider, or other exceptional 
                circumstance demonstrated by the participating 
                provider;
                    ``(D) a prescription issued by a participating 
                provider under circumstances in which, notwithstanding 
                the participating provider's ability to submit a 
                prescription electronically as required by this 
                subsection, such participating provider reasonably 
                determines that it would be impractical for the 
                individual involved to obtain substances prescribed by 
                electronic prescription in a timely manner, and such 
                delay would adversely impact the individual involved's 
                medical condition involved;
                    ``(E) a prescription issued by a participating 
                provider prescribing a drug under a research protocol;
                    ``(F) a prescription issued by a participating 
                provider for a drug for which the Food and Drug 
                Administration requires a prescription to contain 
                elements that are not able to be included in electronic 
                prescribing, such as a drug with risk evaluation and 
                mitigation strategies that include elements to assure 
                safe use;
                    ``(G) a prescription issued for an individual who 
                receives hospice care or for a resident of a nursing 
                facility (as defined in section 1919(a) of the Social 
                Security Act);
                    ``(H) a prescription issued under circumstances in 
                which electronic prescribing is not available due to 
                temporary technological or electrical failure, as 
                specified jointly by the Secretary, the Secretary of 
                Labor, and the Secretary of the Treasury through 
                rulemaking; and
                    ``(I) a prescription issued by a participating 
                provider allowing for the dispensing of a non-patient 
                specific prescription pursuant to a standing order, 
                approved protocol for drug therapy, collaborative drug 
                management, or comprehensive medication management, in 
                response to a public health emergency or other 
                circumstances under which the participating provider 
                may issue a non-patient specific prescription.
            ``(3) Rules of construction.--
                    ``(A) Verification.--Nothing in this subsection 
                shall be construed as requiring a dispenser to verify 
                that a participating provider, with respect to a 
                prescription for a schedule II, III, IV, or V 
                controlled substance that is a prescription drug 
                covered by a group health plan or group or individual 
                health insurance coverage offered by a health insurance 
                issuer, has a waiver (or is otherwise exempt) under 
                paragraph (2) from the requirement under paragraph (1).
                    ``(B) Authority to dispense.--Nothing in this 
                subsection shall be construed as affecting the 
                authority of a group health plan or group or individual 
                health insurance coverage offered by a health insurance 
                issuer to cover, or the authority of a dispenser to 
                continue to dispense, a prescription drug if the 
                prescription for such drug is an otherwise valid 
                written, oral, or fax prescription that is consistent 
                with applicable law.
                    ``(C) Patient choice.--Nothing in this subsection 
                shall be construed as affecting the ability of an 
                individual who is a participant, beneficiary, or 
                enrollee of a group health plan or group or individual 
                health insurance coverage offered by a health insurance 
                issuer and who is prescribed a schedule II, III, IV, or 
                V controlled substance that is a prescription drug 
                covered by the plan or coverage to designate a 
                particular dispenser to dispense a prescribed 
                controlled substance to the extent consistent with the 
                requirements under this subsection.
            ``(4) Regulations on policy requirements.--The Secretary, 
        the Secretary of Labor, and the Secretary of the Treasury shall 
        promulgate regulations specifying requirements for the policies 
        established by group health plans and health insurance issuers 
        under paragraph (1). Such regulations shall include 
        requirements for--
                    ``(A) a uniform process by which plans and issuers 
                are required to set the e-prescribing requirements;
                    ``(B) a process by which plans and issuers are 
                required to grant waivers and exceptions to 
                participating providers pursuant to paragraph (2); and
                    ``(C) a mechanism for plans and issuers to 
                recognize waivers issued to participating providers 
                under part D of title XVIII of the Social Security Act, 
                pursuant to paragraph (2)(C).
            ``(5) Prohibitions.--The policies established pursuant to 
        paragraph (1) by a group health plan or health insurance issuer 
        offering group or individual health insurance coverage may 
        not--
                    ``(A) require dispensers of a schedule II, III, IV, 
                or V controlled substance to confirm that the 
                prescription for the controlled substance was 
                electronically issued by a participating provider in 
                accordance with such policies, as described in 
                paragraph (1);
                    ``(B) require dispensers of such controlled 
                substances to submit information or data beyond what is 
                otherwise required to process a prescription drug claim 
                in order to confirm a participating provider's 
                compliance with such policies;
                    ``(C) reject, deny, or recoup reimbursement for a 
                prescription drug claim based on the format in which 
                the prescription was issued; or
                    ``(D) require a participating provider to use a 
                specific vendor for electronic prescribing or a 
                specific electronic prescribing product or system.
            ``(6) Attestation of compliance.--Beginning on January 1, 
        2026, each group health plan and health insurance issuer 
        offering group or individual health insurance coverage shall 
        annually submit to the Secretary, the Secretary of Labor, and 
        the Secretary of the Treasury an attestation of compliance with 
        the requirements of this subsection.
            ``(7) Consultation requirement for rulemaking.--In 
        promulgating regulations to carry out this subsection, the 
        Secretary, the Secretary of the Labor, and the Secretary of the 
        Treasury shall jointly consult with dispensers of controlled 
        substances, State insurance regulators, and health care 
        practitioners.''.
    (b) Employee Retirement Income Security Act of 1974 Amendment.--
Section 722 of the Employee Retirement Income Security Act of 1974 (29 
U.S.C. 1185k) is amended by adding at the end the following new 
subsection:
    ``(d) Requirements for Electronic-prescribing for Controlled 
Substances.--
            ``(1) In general.--Except as provided pursuant to paragraph 
        (2), for plan years beginning on or after January 1, 2026, a 
        group health plan and a health insurance issuer offering group 
        health insurance coverage, with respect to a participating 
        provider, as defined in section 716(a)(3), shall have in place 
        policies, subject to paragraphs (4) and (5), that require any 
        prescription for a schedule II, III, IV, or V controlled 
        substance (as defined by section 202 of the Controlled 
        Substances Act) covered by the plan or coverage that is 
        transmitted by such a participating provider for such a 
        participant or beneficiary be electronically transmitted 
        consistent with standards established under paragraph (3) of 
        section 1860D-4(e) of the Social Security Act, under an 
        electronic prescription drug program that meets requirements 
        that are substantially similar (as jointly determined by the 
        Secretary, the Secretary of Health and Human Services, and the 
        Secretary of the Treasury) to the requirements of paragraph (2) 
        of such section 1860D-4(e).
            ``(2) Exception for certain circumstances.--The Secretary, 
        the Secretary of Health and Human Services, and the Secretary 
        of the Treasury shall jointly, through rulemaking, specify 
        circumstances and processes by which the requirement under 
        paragraph (1) may be waived, with respect to a schedule II, 
        III, IV, or V controlled substance that is a prescription drug 
        covered by a group health plan or group health insurance 
        coverage offered by a health insurance issuer, including in the 
        case of--
                    ``(A) a prescription issued when the participating 
                provider and dispensing pharmacy are the same entity;
                    ``(B) a prescription issued that cannot be 
                transmitted electronically under the most recently 
                implemented version of the National Council for 
                Prescription Drug Programs SCRIPT Standard;
                    ``(C) a prescription issued by a participating 
                provider who received a waiver (which may include a 
                waiver obtained pursuant to section 1860D-
                4(e)(7)(B)(iii) of the Social Security Act) or a 
                renewal thereof for a period of time as determined by 
                the Secretary, the Secretary of Health and Human 
                Services, and the Secretary of the Treasury, not to 
                exceed one year, from the requirement to use electronic 
                prescribing due to demonstrated economic hardship, 
                technological limitations that are not reasonably 
                within the control of the participating provider, or 
                other exceptional circumstance demonstrated by the 
                participating provider;
                    ``(D) a prescription issued by a participating 
                provider under circumstances in which, notwithstanding 
                the participating provider's ability to submit a 
                prescription electronically as required by this 
                subsection, such participating provider reasonably 
                determines that it would be impractical for the 
                individual involved to obtain substances prescribed by 
                electronic prescription in a timely manner, and such 
                delay would adversely impact the individual's medical 
                condition involved;
                    ``(E) a prescription issued by a participating 
                provider prescribing a drug under a research protocol;
                    ``(F) a prescription issued by a participating 
                provider for a drug for which the Food and Drug 
                Administration requires a prescription to contain 
                elements that are not able to be included in electronic 
                prescribing, such as a drug with risk evaluation and 
                mitigation strategies that include elements to assure 
                safe use;
                    ``(G) a prescription issued for an individual who 
                receives hospice care or for a resident of a nursing 
                facility (as defined in section 1919(a) of the Social 
                Security Act);
                    ``(H) a prescription issued under circumstances in 
                which electronic prescribing is not available due to 
                temporary technological or electrical failure, as 
                specified jointly by the Secretary, the Secretary of 
                Health and Human Services, and the Secretary of the 
                Treasury through rulemaking; and
                    ``(I) a prescription issued by a participating 
                provider allowing for the dispensing of a non-patient 
                specific prescription pursuant to a standing order, 
                approved protocol for drug therapy, collaborative drug 
                management, or comprehensive medication management, in 
                response to a public health emergency or other 
                circumstances under which the participating provider 
                may issue a non-patient specific prescription.
            ``(3) Rules of construction.--
                    ``(A) Verification.--Nothing in this subsection 
                shall be construed as requiring a dispenser to verify 
                that a participating provider, with respect to a 
                prescription for a schedule II, III, IV, or V 
                controlled substance that is a prescription drug 
                covered by a group health plan or group or individual 
                health insurance coverage offered by a health insurance 
                issuer, has a waiver (or is otherwise exempt) under 
                paragraph (2) from the requirement under paragraph (1).
                    ``(B) Authority to dispense.--Nothing in this 
                subsection shall be construed as affecting the 
                authority of a group health plan or group health 
                insurance coverage offered by a health insurance issuer 
                to cover, or the authority of a dispenser to continue 
                to dispense, a prescription drug if the prescription 
                for such drug is an otherwise valid written, oral, or 
                fax prescription that is consistent with applicable 
                law.
                    ``(C) Patient choice.--Nothing in this subsection 
                shall be construed as affecting the ability of an 
                individual who is a participant or beneficiary of a 
                group health plan or group or individual health 
                insurance coverage offered by a health insurance issuer 
                and who is prescribed a schedule II, III, IV, or V 
                controlled substance that is a prescription drug 
                covered by the plan or coverage to designate a 
                particular dispenser to dispense a prescribed 
                controlled substance to the extent consistent with the 
                requirements under this subsection.
            ``(4) Regulations on policy requirements.--The Secretary, 
        the Secretary of Health and Human Services, and the Secretary 
        of the Treasury shall promulgate regulations specifying 
        requirements for the policies established by group health plans 
        and health insurance issuers under paragraph (1). Such 
        regulations shall include requirements for--
                    ``(A) a uniform process by which plans and issuers 
                are required to set the e-prescribing requirements;
                    ``(B) a process by which plans and issuers are 
                required to grant waivers and exceptions to 
                participating providers pursuant to paragraph (2); and
                    ``(C) a mechanism for plans and issuers to 
                recognize waivers issued to participating providers 
                under part D of title XVIII of the Social Security Act, 
                pursuant to paragraph (2)(C).
            ``(5) Prohibitions.--The policies established pursuant to 
        paragraph (1) by a group health plan or health insurance issuer 
        offering group health insurance coverage may not--
                    ``(A) require dispensers of a schedule II, III, IV, 
                or V controlled substance to confirm that the 
                prescription for the controlled substance was 
                electronically issued by a participating provider in 
                accordance with such policies, as described in 
                paragraph (1);
                    ``(B) require dispensers of such controlled 
                substances to submit information or data beyond what is 
                otherwise required to process a prescription drug claim 
                in order to confirm a participating provider's 
                compliance with such policies;
                    ``(C) reject, deny, or recoup reimbursement for a 
                prescription drug claim based on the format in which 
                the prescription was issued; or
                    ``(D) require a participating provider to use a 
                specific vendor for electronic prescribing or a 
                specific electronic prescribing product or system.
            ``(6) Attestation of compliance.--Beginning on January 1, 
        2026, each group health plan and health insurance issuer 
        offering group health insurance coverage shall annually submit 
        to the Secretary, the Secretary of Health and Human Services, 
        and the Secretary of the Treasury an attestation of compliance 
        with the requirements of this subsection.
            ``(7) Consultation requirement for rulemaking.--In 
        promulgating regulations to carry out this subsection, the 
        Secretary, the Secretary of Health and Human Services, and the 
        Secretary of the Treasury shall jointly consult with dispensers 
        of controlled substances, State insurance regulators, and 
        health care practitioners.''.
    (c) Internal Revenue Code of 1986 Amendment.--Section 9822 of the 
Internal Revenue Code of 1986 is amended by adding at the end the 
following new subsection:
    ``(d) Requirements for Electronic-Prescribing for Controlled 
Substances.--
            ``(1) In general.--Except as provided pursuant to paragraph 
        (2), for plan years beginning on or after January 1, 2026, a 
        group health plan, with respect to a participating provider, as 
        defined in section 9816(a)(3), shall have in place policies, 
        subject to paragraphs (4) and (5), that require any 
        prescription for a schedule II, III, IV, or V controlled 
        substance (as defined by section 202 of the Controlled 
        Substances Act) covered by the plan that is transmitted by such 
        a participating provider for such a participant or beneficiary 
        be electronically transmitted consistent with standards 
        established under paragraph (3) of section 1860D-4(e) of the 
        Social Security Act, under an electronic prescription drug 
        program that meets requirements that are substantially similar 
        (as jointly determined by the Secretary, the Secretary of 
        Health and Human Services, and the Secretary of Labor) to the 
        requirements of paragraph (2) of such section 1860D-4(e).
            ``(2) Exception for certain circumstances.--The Secretary, 
        the Secretary of Health and Human Services, and the Secretary 
        of Labor shall jointly, through rulemaking, specify 
        circumstances and processes by which the requirement under 
        paragraph (1) may be waived, with respect to a schedule II, 
        III, IV, or V controlled substance that is a prescription drug 
        covered by a group health, including in the case of--
                    ``(A) a prescription issued when the participating 
                provider and dispensing pharmacy are the same entity;
                    ``(B) a prescription issued that cannot be 
                transmitted electronically under the most recently 
                implemented version of the National Council for 
                Prescription Drug Programs SCRIPT Standard;
                    ``(C) a prescription issued by a participating 
                provider who received a waiver (which may include a 
                waiver obtained pursuant to section 1860D-
                4(e)(7)(B)(iii) of the Social Security Act) or a 
                renewal thereof for a period of time as determined by 
                the Secretary, the Secretary of Health and Human 
                Services, and the Secretary of Labor, not to exceed one 
                year, from the requirement to use electronic 
                prescribing due to demonstrated economic hardship, 
                technological limitations that are not reasonably 
                within the control of the participating provider, or 
                other exceptional circumstance demonstrated by the 
                participating provider;
                    ``(D) a prescription issued by a participating 
                provider under circumstances in which, notwithstanding 
                the participating provider's ability to submit a 
                prescription electronically as required by this 
                subsection, such participating provider reasonably 
                determines that it would be impractical for the 
                individual involved to obtain substances prescribed by 
                electronic prescription in a timely manner, and such 
                delay would adversely impact the individual's medical 
                condition involved;
                    ``(E) a prescription issued by a participating 
                provider prescribing a drug under a research protocol;
                    ``(F) a prescription issued by a participating 
                provider for a drug for which the Food and Drug 
                Administration requires a prescription to contain 
                elements that are not able to be included in electronic 
                prescribing, such as a drug with risk evaluation and 
                mitigation strategies that include elements to assure 
                safe use;
                    ``(G) a prescription issued for an individual who 
                receives hospice care or for a resident of a nursing 
                facility (as defined in section 1919(a) of the Social 
                Security Act);
                    ``(H) a prescription issued under circumstances in 
                which electronic prescribing is not available due to 
                temporary technological or electrical failure, as 
                specified jointly by the Secretary, the Secretary of 
                Health and Human Services, and the Secretary of Labor 
                through rulemaking; and
                    ``(I) a prescription issued by a participating 
                provider allowing for the dispensing of a non-patient 
                specific prescription pursuant to a standing order, 
                approved protocol for drug therapy, collaborative drug 
                management, or comprehensive medication management, in 
                response to a public health emergency or other 
                circumstances under which the participating provider 
                may issue a non-patient specific prescription.
            ``(3) Rules of construction.--
                    ``(A) Verification.--Nothing in this subsection 
                shall be construed as requiring a dispenser to verify 
                that a participating provider, with respect to a 
                prescription for a schedule II, III, IV, or V 
                controlled substance that is a prescription drug 
                covered by a group health plan, has a waiver (or is 
                otherwise exempt) under paragraph (2) from the 
                requirement under paragraph (1).
                    ``(B) Authority to dispense.--Nothing in this 
                subsection shall be construed as affecting the ability 
                of a group health plan to cover, or the ability of a 
                dispenser to continue to dispense, a prescription drug 
                if the prescription for such drug is an otherwise valid 
                written, oral, or fax prescription that is consistence 
                with applicable laws and regulations.
                    ``(C) Patient choice.--Nothing in this subsection 
                shall be construed as affecting the ability of an 
                individual who is a participant or beneficiary of a 
                group health plan and who is prescribed a schedule II, 
                III, IV, or V controlled substance that is a 
                prescription drug covered by the plan to designate a 
                particular dispenser to dispense a prescribed 
                controlled substance to the extent consistent with the 
                requirements under this subsection.
            ``(4) Regulations on policy requirements.--The Secretary, 
        the Secretary of Health and Human Services, and the Secretary 
        of Labor shall promulgate regulations specifying requirements 
        for the policies established by group health plans under 
        paragraph (1). Such regulations shall include requirements 
        for--
                    ``(A) a uniform process by which plans are required 
                to set the e-prescribing requirements;
                    ``(B) a process by which plans are required to 
                grant waivers and exceptions to participating providers 
                pursuant to paragraph (2); and
                    ``(C) a mechanism for plans to recognize waivers 
                issued to participating providers under part D of title 
                XVIII of the Public Health Service Act, pursuant to 
                paragraph (2)(C).
            ``(5) Prohibitions.--The policies established pursuant to 
        paragraph (1) by a group health plan may not--
                    ``(A) require dispensers of a schedule II, III, IV, 
                or V controlled substance to confirm that the 
                prescription for the controlled substance was 
                electronically issued by a participating provider in 
                accordance with such policies, as described in 
                paragraph (1);
                    ``(B) require dispensers of such controlled 
                substances to submit information or data beyond what is 
                otherwise required to process a prescription drug claim 
                in order to confirm a participating provider's 
                compliance with such policies;
                    ``(C) reject, deny, or recoup reimbursement for a 
                prescription drug claim based on the format in which 
                the prescription was issued; or
                    ``(D) require a participating provider to use a 
                specific vendor for electronic prescribing or a 
                specific electronic prescribing product or system.
            ``(6) Attestation of compliance.--Beginning on January 1, 
        2026, each group health plan shall annually submit to the 
        Secretary, the Secretary of Health and Human Services, and the 
        Secretary of Labor an attestation of compliance with the 
        requirements of this subsection.
            ``(7) Consultation requirement for rulemaking.--In 
        promulgating regulations to carry out this subsection, the 
        Secretary, the Secretary of Health and Human Services, and the 
        Secretary of Labor shall jointly consult with dispensers of 
        controlled substances, State insurance regulators, and health 
        care practitioners.''.
    (d) Update of Biometric Component of Multifactor Authentication.--
Not later than 1 year after the date of enactment of this Act, the 
Attorney General shall finalize a regulation updating the requirements 
for the biometric component of multifactor authentication with respect 
to electronic prescriptions of controlled substances, as required under 
section 2003(c) of the SUPPORT for Patients and Community Act (Public 
Law 115-271).

                          TITLE II--TREATMENT

SEC. 201. RESIDENTIAL TREATMENT PROGRAM FOR PREGNANT AND POSTPARTUM 
              WOMEN.

    Section 508 of the Public Health Service Act (42 U.S.C. 290bb-1) is 
amended--
            (1) in subsection (d)(11)(C), by striking ``providing 
        health services'' and inserting ``providing health care 
        services'';
            (2) in subsection (g)--
                    (A) by inserting ``a plan describing'' after ``will 
                provide''; and
                    (B) by adding at the end the following: ``Such plan 
                may include a description of how such applicant will 
                target outreach to women disproportionately impacted by 
                maternal substance use disorder.''; and
            (3) in subsection (s), by striking ``$29,931,000 for each 
        of fiscal years 2019 through 2023'' and inserting ``$38,931,000 
        for each of fiscal years 2024 through 2028''.

SEC. 202. LOAN REPAYMENT PROGRAM FOR SUBSTANCE USE DISORDER TREATMENT 
              WORKFORCE.

    Section 781(j) of the Public Health Service Act (42 U.S.C. 295h(j)) 
is amended by striking ``$25,000,000 for each of fiscal years 2019 
through 2023'' and inserting ``$50,000,000 for each of fiscal years 
2024 through 2028''.

SEC. 203. REGIONAL CENTERS OF EXCELLENCE IN SUBSTANCE USE DISORDER 
              EDUCATION.

    Section 551 of the Public Health Service Act (42 U.S.C. 290ee-6) is 
amended by striking subsection (f).

SEC. 204. MENTAL AND BEHAVIORAL HEALTH EDUCATION AND TRAINING PROGRAM.

    Section 756(f) of the Public Health Service Act (42 U.S.C. 294e-
1(f)) is amended to read as follows:
    ``(f) Authorization of Appropriations.--To carry out this section, 
there is authorized to be appropriated the following:
            ``(1) $50,000,000 for fiscal year 2024, to be allocated as 
        follows:
                    ``(A) For grants described in subsection (a)(1), 
                $15,000,000.
                    ``(B) For grants described in subsection (a)(2), 
                $15,000,000.
                    ``(C) For grants described in subsection (a)(3), 
                $10,000,000.
                    ``(D) For grants described in subsection (a)(4), 
                $10,000,000.
            ``(2) $55,000,000 for fiscal year 2025, to be allocated as 
        follows:
                    ``(A) For grants described in subsection (a)(1), 
                $16,500,000.
                    ``(B) For grants described in subsection (a)(2), 
                $16,500,000.
                    ``(C) For grants described in subsection (a)(3), 
                $11,000,000.
                    ``(D) For grants described in subsection (a)(4), 
                $11,000,000.
            ``(3) $60,000,000 for fiscal year 2026, to be allocated as 
        follows:
                    ``(A) For grants described in subsection (a)(1), 
                $18,000,000.
                    ``(B) For grants described in subsection (a)(2), 
                $18,000,000.
                    ``(C) For grants described in subsection (a)(3), 
                $12,000,000.
                    ``(D) For grants described in subsection (a)(4), 
                $12,000,000.
            ``(4) $65,000,000 for fiscal year 2027, to be allocated as 
        follows:
                    ``(A) For grants described in subsection (a)(1), 
                $19,500,000.
                    ``(B) For grants described in subsection (a)(2), 
                $19,500,000.
                    ``(C) For grants described in subsection (a)(3), 
                $13,000,000.
                    ``(D) For grants described in subsection (a)(4), 
                $13,000,000.
            ``(5) $75,000,000 for fiscal year 2028, to be allocated as 
        follows:
                    ``(A) For grants described in subsection (a)(1), 
                $22,500,000.
                    ``(B) For grants described in subsection (a)(2), 
                $22,500,000.
                    ``(C) For grants described in subsection (a)(3), 
                $15,000,000.
                    ``(D) For grants described in subsection (a)(4), 
                $15,000,000.''.

SEC. 205. GRANTS TO ENHANCE ACCESS TO SUBSTANCE USE DISORDER TREATMENT.

    Section 3203 of the SUPPORT for Patients and Communities Act (21 
U.S.C. 823 note) is amended--
            (1) by striking subsection (b); and
            (2) by striking ``In General--The Secretary'' and inserting 
        the following:
``The Secretary''.

SEC. 206. GRANTS TO IMPROVE TRAUMA SUPPORT SERVICES AND MENTAL HEALTH 
              CARE FOR CHILDREN AND YOUTH IN EDUCATIONAL SETTINGS.

    Section 7134 of the SUPPORT for Patients and Communities Act (42 
U.S.C. 280h-7) is amended--
            (1) in subsection (a), by striking ``tribal'' and inserting 
        ``Tribal'';
            (2) in subsection (c)--
                    (A) in paragraph (1), by inserting ``early 
                intervention,'' after ``screening,'';
                    (B) in paragraph (3)--
                            (i) in the matter preceding subparagraph 
                        (A), by inserting ``other staff,'' after 
                        ``support personnel,''; and
                            (ii) in subparagraph (A), by striking 
                        ``social and emotional learning'' and inserting 
                        ``developmentally appropriate practices''; and
                    (C) in paragraph (5), by inserting ``reduce stigma 
                associated with mental health care and'' after 
                ``efforts to'';
            (3) in subsection (d)--
                    (A) in paragraph (4)--
                            (i) in subparagraph (A), by striking ``; 
                        and'' and inserting a semicolon;
                            (ii) in subparagraph (B)--
                                    (I) by striking ``tribal 
                                organizations as appropriate, other 
                                school personnel'' and inserting 
                                ``Tribal organizations as appropriate, 
                                other staff''; and
                                    (II) by striking the period and 
                                inserting ``; and''; and
                            (iii) by adding at the end the following:
                    ``(C) parents and guardians will be informed of 
                what trauma support services and mental health care are 
                available to their students and what services and care 
                their students receive, in accordance with the parental 
                consent requirements under subsection (h)(2).''; and
                    (B) by adding at the end the following:
            ``(7) A plan for sustaining the program following the end 
        of the award period.'';
            (4) in subsection (f)(1), by inserting ``, which shall 
        include a description of how the school obtains consent from 
        the student's parent or guardian for the provision of trauma 
        support services and mental health care'' after ``this 
        section'';
            (5) in subsection (g), by striking ``tribal'' and inserting 
        ``Tribal'';
            (6) in subsection (h)--
                    (A) in the subsection heading, by inserting ``; 
                Application of Certain Provisions'' after 
                ``Construction'';
                    (B) by striking ``tribal'' each place it appears 
                and inserting ``Tribal'';
                    (C) by redesignating paragraphs (1) and (2) as 
                subparagraphs (A) and (B), respectively, and adjusting 
                the margins accordingly;
                    (D) by striking ``Nothing in this section'' and 
                inserting the following:
            ``(1) In general.--Nothing in this section''; and
                    (E) by adding at the end the following:
            ``(2) Application of provisions.--
                    ``(A) Rules.--Section 4001 of the Elementary and 
                Secondary Education Act of 1965 (not including the 
                exception under subsection (a)(2)(B)(i) of such 
                section) shall apply to an entity receiving a grant, 
                contract, or cooperative agreement under this section 
                in the same manner as such section 4001 applies to an 
                entity receiving funding under title IV of such Act.
                    ``(B) Privacy protections.--Any education record of 
                a student collected or maintained under subsection 
                (c)(4) shall have the protections required for 
                education records under section 444 of the General 
                Education Provisions Act.''.
            (7) in subsection (k)--
                    (A) by redesignating paragraphs (5) through (11) as 
                paragraphs (6) through (12), respectively; and
                    (B) by inserting after paragraph (4) the following:
            ``(5) Other staff.--The term `other staff' has the meaning 
        given such term in section 8101 of the Elementary and Secondary 
        Education Act of 1965.''; and
            (8) in subsection (l), by striking ``2019 through 2023'' 
        and inserting ``2024 through 2028''.

SEC. 207. DEVELOPMENT AND DISSEMINATION OF MODEL TRAINING PROGRAMS FOR 
              SUBSTANCE USE DISORDER PATIENT RECORDS.

    Section 7053 of the SUPPORT for Patients and Communities Act (42 
U.S.C. 290dd-2 note) is amended by striking subsection (e).

SEC. 208. TASK FORCE ON BEST PRACTICES FOR TRAUMA-INFORMED 
              IDENTIFICATION, REFERRAL, AND SUPPORT.

    Section 7132 of the SUPPORT for Patients and Communities Act 
(Public Law 115-271; 132 Stat. 4046) is amended--
            (1) in subsection (b)(1)--
                    (A) by redesignating subparagraph (CC) as 
                subparagraph (DD); and
                    (B) by inserting after subparagraph (BB) the 
                following:
                    ``(CC) The Administration for Community Living.'';
            (2) in subsection (d)(1), in the matter preceding 
        subparagraph (A), by inserting ``, developmental disability 
        service providers'' before ``, individuals who are''; and
            (3) in subsection (i), by striking ``2023'' and inserting 
        ``2028''.

SEC. 209. PROGRAM TO SUPPORT COORDINATION AND CONTINUATION OF CARE FOR 
              DRUG OVERDOSE PATIENTS.

    Section 7081 of the SUPPORT for Patients and Communities Act (42 
U.S.C. 290dd-4) is amended by striking subsection (f).

SEC. 210. REGULATIONS RELATING TO SPECIAL REGISTRATION FOR 
              TELEMEDICINE.

    Not later than 1 year after the date of enactment of this Act, the 
Attorney General, in consultation with the Secretary of Health and 
Human Services, shall promulgate the final regulations required under 
section 311(h)(2) of the Controlled Substances Act (21 U.S.C. 
831(h)(2)).

SEC. 211. MENTAL HEALTH PARITY.

    (a) In General.--Not later than January 1, 2025, the Inspector 
General of the Department of Labor, in coordination with the Inspector 
General of the Department of Health and Human Services, shall report to 
the Committee on Health, Education, Labor, and Pensions of the Senate 
and the Committee on Energy and Commerce and the Committee on Education 
and the Workforce of the House of Representatives on the following:
            (1) The non-quantitative treatment limit (referred to in 
        this section as ``NQTL'') requirements with respect to mental 
        health and substance use disorder benefits under group health 
        plans and health insurance issuers under section 2726(a)(8) of 
        the Public Health Service Act (42 U.S.C. 300gg-26(a)(8)), 
        section 712(a)(8) of the Employee Retirement Income Security 
        Act of 1974 (29 U.S.C. 1185a(a)(8)), and section 9812(a)(8) of 
        the Internal Revenue Code of 1986 (referred to in this section 
        as the ``NQTL comparative analysis requirements''), and the 
        requirements for the Secretary of Health and Human Services, 
        the Secretary of Labor, and the Secretary of the Treasury to 
        issue regulations, a compliance program guide, and additional 
        guidance documents and tools providing guidance relating to 
        mental health parity requirements under section 2726(a) of the 
        Public Health Service Act (42 U.S.C. 300gg-26(a)), section 
        712(a) of the Employee Retirement Income Security Act of 1974 
        (29 U.S.C. 1185a(a)), and section 9812(a) of the Internal 
        Revenue Code of 1986.
            (2) With respect to the NQTL comparative analysis 
        requirements described in paragraph (1), an analysis of the 
        actions taken by the Secretary of Labor, the Secretary of the 
        Treasury, and the Secretary of Health and Human Services to 
        provide guidance to ensure that group health plans and health 
        insurance issuers can fully comply with mental health parity 
        requirements under section 2726 of the Public Health Service 
        Act (42 U.S.C. 300gg-26), section 712 of the Employee 
        Retirement Income Security Act of 1974 (29 U.S.C. 1185a), and 
        section 9812 of the Internal Revenue Code of 1986 and the NQTL 
        comparative analysis requirements described in paragraph (1), 
        including an analysis of--
                    (A) the extent to which the Secretary of Labor, the 
                Secretary of the Treasury, and the Secretary of Health 
                and Human Services have fulfilled the requirement under 
                section 203(b) of division BB of the Consolidated 
                Appropriations Act, 2021 (Public Law 116-260) to issue 
                the specific guidance and regulations pertaining to the 
                requirements for group health plans and health 
                insurance issuers to demonstrate compliance with the 
                NQTL comparative analysis requirements; and
                    (B) whether sufficient guidance and examples from 
                the Department of Labor and Department of Health and 
                Human Services, and the Department of the Treasury 
                exist to guide and assist group health plans and health 
                insurance issuers in complying with the requirements to 
                demonstrate compliance with mental health parity NQTL 
                comparative analysis requirements/under such sections 
                2726(a)(8), 712(a)(8), and 9812(a)(8).
            (3) A review of the enforcement processes of the Department 
        of Labor and the Department of Health and Human Services to 
        evaluate the consistency of interpretation of the requirements 
        under section 2726(a)(8) of the Public Health Service Act (42 
        U.S.C. 300gg-26(a)(8)), section 712(a)(8) of the Employee 
        Retirement Income Security Act of 1974 (29 U.S.C. 1185a(a)(8)), 
        and section 9812(a)(8) of the Internal Revenue Code of 1986, in 
        particular with respect to processes utilized for enforcement, 
        actions or inactions that constitute noncompliance, and 
        avoidance among the agencies of duplication of enforcement, 
        including an evaluation of compliance with section 104 of the 
        Health Insurance Portability and Accountability Act of 1996 
        (Public Law 104-191).
            (4) A review of the implementation, by the Department of 
        Labor, Department of Health and Human Services, and Department 
        of the Treasury, of mental health parity requirements under 
        section 2726 of the Public Health Service Act (42 U.S.C. 300gg-
        26), section 712 of the Employee Retirement Income Security Act 
        of 1974 (29 U.S.C. 1185a), and section 9812 of the Internal 
        Revenue Code of 1986, including all such requirements in effect 
        through the enactment of the Mental Health Parity Act of 1996 
        (Public Law 104-204), the Paul Wellstone and Pete Domenici 
        Mental Health Parity and Addiction Equity Act of 2008 (Public 
        Law 110-460), the 21st Century Cures Act (Public Law 114-255), 
        and the Consolidated Appropriations Act, 2023 (Public Law 117-
        328) (including any amendments made by such Acts), and 
        including with respect to the timing of all actions, delays of 
        any actions, reasons for any such delays, mandated requirements 
        that were met only once but not each time such requirements 
        were mandated.
    (b) Definitions.--In this section, the terms ``group health plan'' 
and ``health insurance issuer'' have the meanings given such terms in 
section 733 of the Employee Retirement Income Security Act of 1974 (29 
U.S.C. 1191b).

SEC. 212. STATE GUIDANCE RELATED TO INDIVIDUALS WITH SERIOUS MENTAL 
              ILLNESS AND CHILDREN WITH SERIOUS EMOTIONAL DISTURBANCE.

    (a) Review of Use of Certain Funding.--Not later than 1 year after 
the date of enactment of this Act, the Secretary of Health and Human 
Services, acting through the Assistant Secretary for Mental Health and 
Substance Use, shall conduct a review of the use by States of funds 
made available under the Community Mental Health Services Block Grant 
program under subpart I of part B of title XIX of the Public Health 
Service Act (42 U.S.C. 300x et seq.) for First Episode Psychosis 
activities. Such review shall consider the following:
            (1) How the States use funds for evidence-based treatments 
        and services, such as coordinated specialty care, according to 
        the standard of care for individuals with early serious mental 
        illness, including the comprehensiveness of such treatments to 
        include all aspects of the recommended intervention.
            (2) How State mental health departments coordinate with 
        State Medicaid departments in the delivery of the treatments 
        and services described in paragraph (1).
            (3) The percentage of the State funding under the block 
        grant program that is applied toward early serious mental 
        illness, and funding in excess of, or under, 10 percent of the 
        amount of the grant, broken down by State.
            (4) The percentage of funds expended by States through such 
        block grant program specifically on First Episode Psychosis, to 
        the extent such information is available.
            (5) How many individuals are served by the expenditures 
        described in paragraphs (3) and (4), on a per-capita basis.
            (6) How the funds are used to reach underserved 
        populations, including rural populations and racial and ethnic 
        minority populations.
    (b) Report and Guidance.--
            (1) Report.--Not later than 6 months after the completion 
        of the review under subsection (a), the Secretary of Health and 
        Human Services, acting through the Assistant Secretary for 
        Mental Health and Substance Use, shall submit to the Committee 
        on Appropriations, the Committee on Health, Education, Labor, 
        and Pensions, and the Committee on Finance of the Senate and to 
        the Committee on Appropriations and the Committee on Energy and 
        Commerce of the House of Representatives a report on the 
        findings made as a result of the review conducted under 
        subsection (a). Such report shall include any recommendations 
        with respect to any changes to the Community Mental Health 
        Services Block Grant program under subpart I of part B of title 
        XIX of the Public Health Service Act (42 U.S.C. 300x et seq.), 
        including the set-aside required for First Episode Psychosis, 
        that would facilitate improved outcomes for the targeted 
        population involved.
            (2) Guidance.--Not later than 1 year after the date on 
        which the report is submitted under paragraph (1), the 
        Secretary of Health and Human Services, acting through the 
        Assistant Secretary for Mental Health and Substance Use, shall 
        update the guidance provided to States under the Community 
        Mental Health Services Block Grant program based on the 
        findings and recommendations of the report.
    (c) Additional Guidance.--The Director of the National Institute of 
Mental Health shall coordinate with the Assistant Secretary for Mental 
Health and Substance Use in providing guidance to State grantees and 
provider subgrantees about research advances in the delivery of 
services for First Episode Psychosis under the Community Mental Health 
Services Block Grant program.
    (d) Guidance for States Relating to Health Care Services and 
Interventions for Individuals With Serious Mental Illness and Children 
With Serious Emotional Disturbance.--Not later than 2 years after the 
date of enactment of this Act, the Assistant Secretary for Mental 
Health and Substance Use, jointly with the Administrator of the Centers 
for Medicare & Medicaid Services and the Director of the National 
Institute of Mental Health--
            (1) shall provide updated guidance to States concerning the 
        manner in which Federal funding provided to States through 
        programs administered by such agencies, including the Community 
        Mental Health Services Block Grant program under subpart I of 
        part B of title XIX of the Public Health Service Act (42 U.S.C. 
        300x et seq.), may be coordinated to provide evidence-based 
        health care services such as coordinated specialty care to 
        individuals with serious mental illness and serious emotional 
        disturbance, and interventions for individuals with early 
        serious mental illness, including First Episode Psychosis; and
            (2) may streamline relevant State reporting requirements if 
        such streamlining would result in making it easier for States 
        to coordinate funding under the programs described in paragraph 
        (1) to improve treatments for individuals with serious mental 
        illness and serious emotional disturbance.

SEC. 213. IMPROVING ACCESS TO ADDICTION MEDICINE PROVIDERS.

    Section 597 of the Public Health Service Act (42 U.S.C. 290ll) is 
amended--
            (1) in subsection (a)(1), by inserting ``diagnosis,'' after 
        ``related to''; and
            (2) in subsection (b), by inserting ``addiction medicine,'' 
        after ``psychiatry,''.

SEC. 214. ROUNDTABLE ON USING HEALTH INFORMATION TECHNOLOGY TO IMPROVE 
              MENTAL HEALTH AND SUBSTANCE USE CARE OUTCOMES.

    (a) Roundtable.--Not later than 180 days after the date of 
enactment of this Act, the Office of the National Coordinator for 
Health Information Technology shall convene a public roundtable to 
examine how the expanded use of electronic health records among mental 
health and substance use service providers can improve outcomes for 
patients in mental health and substance use settings and how best to 
increase electronic health record adoption among such providers.
    (b) Participants.--The National Coordinator for Health Information 
Technology shall ensure that the participants in the roundtable under 
subsection (a) include private and public sector stakeholders, 
including patients, providers (including providers of inpatient 
services and providers of outpatient services), and representatives of 
payors, health information exchanges, professional associations, health 
information technology vendors, health information technology 
certification organizations, and State and Federal agencies.
    (c) Report.--Not later than 180 days after the conclusion of the 
public stakeholder roundtable under subsection (a), the Office of the 
National Coordinator for Health Information Technology shall submit to 
the Committee on Health, Education, Labor, and Pensions of the Senate 
and the Committee on Energy and Commerce of the House of 
Representatives a report outlining information gathered from the 
roundtable under subsection (a). Such report shall include an 
examination of--
            (1) recommendations from the roundtable participants;
            (2) unique considerations for using electronic health 
        record systems in mental health and substance use treatment 
        settings;
            (3) unique considerations for developers of health 
        information technology relating to certification of electronic 
        health records for use in mental health and substance use 
        treatment settings where the applicable health information 
        technology is not currently subject to certification 
        requirements;
            (4) current usage of electronic health records by mental 
        health and substance use disorder service providers, and the 
        scope and magnitude of such providers that do not use 
        electronic health record systems;
            (5) examples of how electronic health record systems enable 
        coordinated care and care management;
            (6) how electronic health record systems further 
        appropriate patient and provider access to secure, usable 
        electronic information exchange;
            (7) how electronic health record systems can be connected 
        to or support existing systems, which may include the 988 
        crisis line, mobile crisis response systems, and co-responder 
        programs, to facilitate connectivity, response, and integrated 
        care;
            (8) any existing programs to support greater adoption of 
        electronic health record systems among mental health and 
        substance use service providers;
            (9) any limitations to greater adoption of electronic 
        health record systems among mental health and substance use 
        service providers;
            (10) the costs of adoption of electronic health record 
        systems by mental health and substance use disorder service 
        providers; and
            (11) best practices implemented by States and by other 
        entities to support adoption of use of electronic health 
        records among mental health and substance use disorder service 
        providers.

SEC. 215. PEER-TO-PEER MENTAL HEALTH SUPPORT.

    (a) In General.--The Assistant Secretary for Mental Health and 
Substance Use (referred to in this section as the ``Assistant 
Secretary''), in consultation with the Secretary of Education, may, as 
appropriate and within a relevant existing program, carry out a pilot 
program and make awards, on a competitive basis, to eligible entities 
to support evidence-based mental health peer support activities for 
students enrolled in secondary schools (as such term is defined in 
section 8101 of the Elementary and Secondary Education Act of 1965 (20 
U.S.C. 7801)).
    (b) Eligibility.--To be eligible to receive an award under this 
section, an entity shall--
            (1) be a State, political subdivision of a State, 
        territory, or Indian Tribe or Tribal organization (as such 
        terms are defined in section 4 of the Indian Self-Determination 
        and Education Assistance Act (25 U.S.C. 5304)); and
            (2) submit to the Assistant Secretary an application at 
        such time, in such manner, and containing such information as 
        the Assistant Secretary may require, including a description of 
        how the entity will measure and evaluate progress of the 
        program in improving student mental health outcomes.
    (c) Use of Amounts.--
            (1) In general.--Subject to paragraph (2), an eligible 
        entity may use amounts provided under this section to implement 
        or operate evidence-based mental health peer support activities 
        in 1 or more secondary schools (as such term is defined in 
        section 8101 of the Elementary and Secondary Education Act of 
        1965 (20 U.S.C. 7801)) within the jurisdiction of such eligible 
        entity, which may include providing training, as appropriate, 
        to students, adult supervisors, and other appropriate 
        individuals to improve the early identification of, response 
        to, and recovery supports for mental health and substance use 
        challenges, reduce associated risks, and promote resiliency.
            (2) Program oversight.--An eligible entity shall ensure 
        that mental health peer support activities under paragraph (1) 
        are overseen by a school-based mental health professional.
            (3) FERPA.--Any education records of the student collected 
        or maintained under this section shall have the protections 
        provided in section 444 of the General Education Provisions Act 
        (20 U.S.C. 1232g).
    (d) Evaluation; Report.--
            (1) Evaluation.--The Assistant Secretary shall carry out an 
        evaluation to measure the efficacy of the program under this 
        section. The evaluation shall--
                    (A) measure participation rates in mental health 
                peer support activities, including any associated 
                trends;
                    (B) describe the specific trainings provided, or 
                other activities carried out under the pilot program;
                    (C) assess whether such mental health peer support 
                activities impacted mental health outcomes of 
                participating students; and
                    (D) measure the effectiveness of the pilot program 
                in connecting students to professional mental health 
                services compared to other evidence-based strategies.
            (2) Report.--The Assistant Secretary shall prepare and 
        submit to the Committee on Health, Education, Labor, and 
        Pensions of the Senate and the Committees on Energy and 
        Commerce and Education and the Workforce of the House of 
        Representatives a report containing the results of the 
        evaluation conducted under paragraph (1).
    (e) Technical Assistance.--The Assistant Secretary, in coordination 
with the Secretary of Education, shall provide technical assistance to 
eligible entities applying for and receiving an award under this 
section, including the identification and dissemination of best 
practices for mental health peer support programs for students.
    (f) Rule of Construction.--Section 4001 of the Elementary and 
Secondary Education Act of 1965 (20 U.S.C. 7101) shall apply to an 
entity receiving a grant, contract, or cooperative agreement under this 
section in the same manner as such section applies to an entity 
receiving funding under title IV of such Act, except that section 
4001(a)(2)(B)(i) of such Act shall not apply.
    (g) Sunset.--This section shall terminate on September 30, 2028.

SEC. 216. KID PROOF PILOT PROGRAM.

    (a) In General.--The Assistant Secretary for Mental Health and 
Substance Use (referred to in this section as the ``Assistant 
Secretary''), may, as appropriate and within a relevant existing 
program, carry out a pilot program and make awards, on a competitive 
basis, to eligible entities to prevent, or reduce the risk of, suicide 
and drug overdose by children, adolescents, and young adults, including 
by addressing the misuse of lethal means commonly used in overdose or 
suicide.
    (b) Eligibility.--To be eligible to receive an award under this 
section, an entity shall--
            (1) be a State, political subdivision of a State, 
        territory, or Indian Tribe or Tribal organization (as such 
        terms are defined in section 4 of the Indian Self-Determination 
        and Education Assistance Act (25 U.S.C. 5304)); and
            (2) submit to the Assistant Secretary an application at 
        such time, in such manner, and containing such information as 
        the Assistant Secretary may require, including a description of 
        the geographic location and settings in which such entity 
        proposes to carry out activities under such award and the 
        demonstrated need of such geographic location and settings.
    (c) Use of Funds.--An eligible entity shall use amounts provided 
under this section to implement evidence-based practices to prevent, or 
reduce the risk of, overdose and suicide among children, adolescents, 
and young adults, including promoting education and awareness among 
parents or legal guardians on relevant best practices and providing 
appropriate supplies to parents or legal guardians to prevent, or 
reduce the risk of, the misuse of lethal means commonly used in 
overdose or suicide.
    (d) Partnerships.--Recipients of funding under this section may 
partner with health care facilities to carry out activities under 
subsection (c).
    (e) Evaluation; Report.--
            (1) Evaluation.--Not later than 2 years after the date on 
        which awards under this section are first issued, the Assistant 
        Secretary shall carry out an evaluation to measure the efficacy 
        of the program under this section. The evaluation shall 
        include--
                    (A) a description of any specific education and 
                awareness activities carried out through the pilot 
                program under this section;
                    (B) the number and types of supplies provided to 
                parents or legal guardians to prevent, or reduce the 
                risk of, the misuse of lethal means commonly used in 
                overdose or suicide; and
                    (C) an assessment of the efficacy of the pilot 
                program in preventing, or reducing the risk of, 
                overdose and suicide.
            (2) Report.--The Assistant Secretary shall prepare and 
        submit to the Committee on Health, Education, Labor, and 
        Pensions of the Senate and the Committee on Energy and Commerce 
        of the House of Representatives a report containing the results 
        of the evaluation conducted under paragraph (1).
    (f) Sunset.--This section shall terminate on September 30, 2028.

                          TITLE III--RECOVERY

SEC. 301. YOUTH PREVENTION AND RECOVERY.

    Section 7102(c) of the SUPPORT for Patients and Communities Act (42 
U.S.C. 290bb-7a(c)) (as amended by section 113(a)) is amended--
            (1) in paragraph (2)--
                    (A) in subparagraph (A)--
                            (i) in clause (i)--
                                    (I) by inserting ``, or a consortia 
                                of local educational agencies,'' after 
                                ``a local educational agency''; and
                                    (II) by striking ``high schools'' 
                                and inserting ``secondary schools''; 
                                and
                            (ii) in clause (vi), by striking ``tribe, 
                        or tribal'' and inserting ``Tribe, or Tribal'';
                    (B) by amending subparagraph (E) to read as 
                follows:
                    ``(E) Indian tribe; tribal organization.--The terms 
                `Indian Tribe' and `Tribal organization' have the 
                meanings given such terms in section 4 of the Indian 
                Self-Determination and Education Assistance Act (25 
                U.S.C. 5304).'';
                    (C) by redesignating subparagraph (K) as 
                subparagraph (L); and
                    (D) by inserting after subparagraph (J) the 
                following:
                    ``(K) Secondary school.--The term `secondary 
                school' has the meaning given such term in section 8101 
                of the Elementary and Secondary Education Act of 1965 
                (20 U.S.C. 7801).'';
            (2) in paragraph (3)(A), in the matter preceding clause 
        (i)--
                    (A) by striking ``and abuse''; and
                    (B) by inserting ``at increased risk for substance 
                misuse'' after ``specific populations'';
            (3) in paragraph (4)--
                    (A) in the matter preceding subparagraph (A), by 
                striking ``Indian tribes'' and inserting ``Indian 
                Tribes'';
                    (B) in subparagraph (A), by striking ``and abuse''; 
                and
                    (C) in subparagraph (B), by striking ``peer 
                mentoring'' and inserting ``peer-to-peer support'';
            (4) in paragraph (5), by striking ``tribal'' and inserting 
        ``Tribal'';
            (5) in paragraph (6)(A)--
                    (A) in clause (iv), by striking ``; and'' and 
                inserting a semicolon; and
                    (B) by adding at the end the following:
                            ``(vi) a plan to sustain the activities 
                        carried out under the grant program, after the 
                        grant program has ended; and'';
            (6) in paragraph (8), by striking ``2022'' and inserting 
        ``2027''; and
            (7) by amending paragraph (9) to read as follows:
            ``(9) Authorization of appropriations.--To carry out this 
        subsection, there are authorized to be appropriated $10,000,000 
        for fiscal year 2024, $12,000,000 for fiscal year 2025, 
        $14,000,000 for fiscal year 2026, $16,000,000 for fiscal year 
        2027, and $18,000,000 for fiscal year 2028.''.

SEC. 302. COMPREHENSIVE OPIOID RECOVERY CENTERS.

    Section 552 of the Public Health Service Act (42 U.S.C. 290ee-7) is 
amended--
            (1) in subsection (d)(2)--
                    (A) in the matter preceding subparagraph (A), by 
                striking ``and in such manner'' and inserting ``, in 
                such manner, and containing such information and 
                assurances''; and
                    (B) in subparagraph (A), by striking ``is capable 
                of coordinating with other entities to carry out'' and 
                inserting ``has the demonstrated capability to carry 
                out, through referral or contractual arrangements'';
            (2) in subsection (h)--
                    (A) by redesignating paragraphs (1) through (4) as 
                subparagraphs (A) through (D), respectively, and 
                adjusting the margins accordingly;
                    (B) by striking ``With respect to'' and inserting 
                the following:
            ``(1) In general.--With respect to''; and
                    (C) by adding at the end the following:
            ``(2) Additional reporting for certain eligible entities.--
        An entity carrying out activities described in subsection (g) 
        through referral or contractual arrangements shall include in 
        the submissions required under paragraph (1) information 
        related to the status of such referrals or contractual 
        arrangements, including an assessment of whether such referrals 
        or contractual arrangements are supporting the ability of such 
        entity to carry out such activities.''; and
            (3) in subsection (j), by striking ``2019 through 2023'' 
        and inserting ``2024 through 2028''.

SEC. 303. BUILDING COMMUNITIES OF RECOVERY.

    Section 547(f) of the Public Health Service Act (42 U.S.C. 290ee-
2(f)) is amended by striking ``$5,000,000 for each of fiscal years 2019 
through 2023'' and inserting ``$16,000,000 for each of fiscal years 
2024 through 2028''.

SEC. 304. PEER SUPPORT TECHNICAL ASSISTANCE CENTER.

    Section 547A of the Public Health Service Act (42 U.S.C. 290ee-2a) 
is amended--
            (1) in subsection (b)(4), by striking ``building; and'' and 
        inserting the following: ``building, such as--
                    ``(A) professional development of peer support 
                specialists; and
                    ``(B) making recovery support services available in 
                nonclinical settings; and'';
            (2) by redesignating subsections (d) and (e) as subsections 
        (e) and (f), respectively;
            (3) by inserting after subsection (c) the following:
    ``(d) Pilot Program.--
            ``(1) In general.--The Secretary shall carry out a pilot 
        program to establish one regional technical assistance center 
        (referred to in this subsection as the `Regional Center') to 
        assist the Center in carrying out activities described in 
        subsection (b) within the geographic region of such Regional 
        Center in a manner that is tailored to the needs of such 
        region.
            ``(2) Evaluation.--Not later than 4 years after the date of 
        enactment of the SUPPORT for Patients and Communities 
        Reauthorization Act, the Secretary shall evaluate the 
        activities of the Regional Center and submit to the Committee 
        on Health, Education, Labor, and Pensions of the Senate and the 
        Committee on Energy and Commerce of the House of 
        Representatives a report on the findings of such evaluation, 
        including--
                    ``(A) a description of the distinct roles and 
                responsibilities of the Regional Center and the Center;
                    ``(B) available information relating to the 
                outcomes of the pilot program under this subsection, 
                such as any impact the Regional Center had on the 
                operations and efficiency of the Center relating to 
                requests for technical assistance and support within 
                the region of such Regional Center;
                    ``(C) a description of any gaps or areas of 
                duplication relating to the activities of the Regional 
                Center and the Center within such region; and
                    ``(D) recommendations relating to the modification, 
                expansion, or termination of the pilot program under 
                this subsection.
            ``(3) Termination.--This subsection shall terminate on 
        September 30, 2028.''; and
            (4) in subsection (f), as so redesignated, by striking 
        ``$1,000,000 for each of fiscal years 2019 through 2023'' and 
        inserting ``$2,000,000 for each of fiscal years 2024 through 
        2028''.

SEC. 305. CAREER ACT.

    (a) In General.--Section 7183 of the SUPPORT for Patients and 
Communities Act (42 U.S.C. 290ee-8) is amended--
            (1) in the section heading, by inserting ``; treatment, 
        recovery, and workforce support grants'' after ``career act'';
            (2) in subsection (b), by inserting ``each'' before ``for a 
        period'';
            (3) in subsection (c)--
                    (A) in paragraph (1), by striking ``the rates 
                described in paragraph (2)'' and inserting ``the 
                average rates for calendar years 2018 through 2022 
                described in paragraph (2)''; and
                    (B) by amending paragraph (2) to read as follows:
            ``(2) Rates.--The rates described in this paragraph are the 
        following:
                    ``(A) The highest age-adjusted average rates of 
                drug overdose deaths for calendar years 2018 through 
                2022 based on data from the Centers for Disease Control 
                and Prevention, including, if necessary, provisional 
                data for calendar year 2022.
                    ``(B) The highest average rates of unemployment for 
                calendar years 2018 through 2022 based on data provided 
                by the Bureau of Labor Statistics.
                    ``(C) The lowest average labor force participation 
                rates for calendar years 2018 through 2022 based on 
                data provided by the Bureau of Labor Statistics.'';
            (4) in subsection (g)--
                    (A) in each of paragraphs (1) and (3), by 
                redesignating subparagraphs (A) and (B) as clauses (i) 
                and (ii), respectively, and adjusting the margins 
                accordingly;
                    (B) by redesignating paragraphs (1) through (3) as 
                subparagraphs (A) through (C), respectively, and 
                adjusting the margins accordingly;
                    (C) in the matter preceding subparagraph (A) (as so 
                redesignated), by striking ``An entity'' and inserting 
                the following:
            ``(1) In general.--An entity''; and
                    (D) by adding at the end the following:
            ``(2) Transportation services.--An entity receiving a grant 
        under this section may use not more than 5 percent of the funds 
        for providing transportation for individuals to participate in 
        an activity supported by a grant under this section, which 
        transportation shall be to or from a place of work or a place 
        where the individual is receiving career and technical 
        education or job training services or receiving services 
        directly linked to treatment of or recovery from a substance 
        use disorder.
            ``(3) Limitation.--The Secretary may not require an entity 
        to, or give priority to an entity that plans to, use the funds 
        of a grant under this section for activities that are not 
        specified in this subsection.'';
            (5) in subsection (i)(2), by inserting ``, which shall 
        include employment and earnings outcomes described in 
        subclauses (I) and (III) of section 116(b)(2)(A)(i) of the 
        Workforce Innovation and Opportunity Act (29 U.S.C. 
        3141(b)(2)(A)(i)) with respect to the participation of such 
        individuals with a substance use disorder in programs and 
        activities funded by the grant under this section'' after 
        ``subsection (g)'';
            (6) in subsection (j)--
                    (A) in paragraph (1), by inserting ``for grants 
                awarded prior to the date of enactment of the SUPPORT 
                for Patients and Communities Reauthorization Act'' 
                after ``grant period under this section''; and
                    (B) in paragraph (2)--
                            (i) in the matter preceding subparagraph 
                        (A), by striking ``2 years after submitting the 
                        preliminary report required under paragraph 
                        (1)'' and inserting ``September 30, 2028''; and
                            (ii) in subparagraph (A), by striking 
                        ``(g)(3)'' and inserting ``(g)(1)(C)''; and
            (7) in subsection (k), by striking ``$5,000,000 for each of 
        fiscal years 2019 through 2023'' and inserting ``$12,000,000 
        for each of fiscal years 2024 through 2028''.
    (b) Clerical Amendment.--The table of contents in section 1(b) of 
the SUPPORT for Patients and Communities Act (Public Law 115-271; 132 
Stat. 3894) is amended by striking the item relating to section 7183 
and inserting the following:

``Sec. 7183. CAREER Act; treatment, recovery, and workforce support 
                            grants.''.

SEC. 306. RESEARCH AND RECOMMENDATIONS ON CRIMINAL BACKGROUND CHECK 
              PROCESS FOR PEER SUPPORT SPECIALISTS.

    (a) In General.--The Secretary of Health and Human Services 
(referred to in this section as the ``Secretary''), in coordination 
with the Attorney General, shall develop a report on research and 
recommendations with respect to criminal background check processes for 
individuals becoming peer support specialists.
    (b) Contents.--The report under subsection (a) shall include--
            (1) a summary of evidence-based research on the 
        effectiveness of peer support specialists in improving the 
        mental health and the substance use disorder recovery of other 
        individuals;
            (2) a survey of each State's laws (including regulations) 
        that contain criminal background check requirements for serving 
        as a peer support specialist, including--
                    (A) an analysis of criminal offenses that are 
                included in State laws (including regulations) that 
                prevent individuals from earning a peer support 
                specialist certification or from practicing as a peer 
                support specialist;
                    (B) an analysis of requirements (if any) under the 
                State plan under title XIX of the Social Security Act 
                (42 U.S.C. 1396 et seq.) or under a waiver of such plan 
                relating to background checks for providers 
                participating under such plan or waiver and the extent 
                to which any such requirements differ from similar 
                requirements imposed under State law (including 
                regulations);
                    (C) an analysis of requirements (if any) of any 
                State receiving a grant under part B of title XIX of 
                the Public Health Service Act (42 U.S.C. 300x et seq.) 
                relating to background checks for providers 
                participating in a program under, or otherwise 
                providing services supported by, such grant;
                    (D) a review of State laws (including regulations) 
                that provide exemptions from prohibitions regarding 
                certification or practice of peer support specialists; 
                and
                    (E) an indication of each State that has gone 
                through the process of amending or otherwise changing 
                criminal background check laws (including regulations) 
                for the certification and practice of peer support 
                specialists; and
            (3) recommendations to States on criminal background check 
        processes that would reduce barriers to becoming certified as 
        peer support specialists.
    (c) Availability.--Not later than 1 year after the date of 
enactment of this Act, the Secretary shall--
            (1) post the report required under subsection (a) on the 
        publicly accessible internet website of the Substance Abuse and 
        Mental Health Services Administration; and
            (2) distribute such report to--
                    (A) State agencies responsible for certification of 
                peer support specialists;
                    (B) the Centers for Medicare & Medicaid Services;
                    (C) State agencies responsible for carrying out a 
                State plan under title XIX of the Social Security Act 
                or under a waiver of such plan; and
                    (D) State agencies responsible for carrying out a 
                grant under part B of title XIX of the Public Health 
                Service Act (42 U.S.C. 300x et seq.).
    (d) Definition of Peer Support Specialist.--
            (1) In general.--In this section, the term ``peer support 
        specialist'' means an individual--
                    (A)(i) who has lived experience of recovery from a 
                mental health condition or substance use disorder and 
                who specializes in supporting individuals with mental 
                health conditions or substance use disorders; or
                    (ii) who has lived experience as a parent or 
                caregiver of an individual with a mental health 
                condition or substance use disorder and who specializes 
                in supporting families navigating mental health or 
                substance use service systems; and
                    (B) who is certified as qualified to furnish peer 
                support services, as described in paragraph (2), under 
                a process that is determined by the State in which such 
                individual furnishes such services or determined 
                appropriate by the Secretary.
            (2) Peer support services.--The services described in this 
        paragraph shall be consistent with the National Practice 
        Guidelines for Peer Supporters issued by the National 
        Association of Peer Supporters (or a successor publication) and 
        inclusive of the Core Competencies for Peer Workers in 
        Behavioral Health Services of the Substance Abuse and Mental 
        Health Services Administration.

SEC. 307. OFFICE OF RECOVERY.

    (a) In General.--There is established, within the Substance Abuse 
and Mental Health Services Administration, an Office of Recovery 
(referred to in this section as the ``Office'').
    (b) Responsibilities.--The Office shall, taking into account the 
perspectives of individuals with demonstrated experience in mental 
health or substance use disorder recovery--
            (1) identify new and emerging challenges related to the 
        provision of recovery support services;
            (2) support technical assistance, data analysis, and 
        evaluation functions in order to assist States, local 
        governmental entities, Indian Tribes, and Tribal organizations 
        in implementing and strengthening recovery support services, 
        consistent with the needs of such States, local governmental 
        entities, Indian Tribes, and Tribal organizations; and
            (3) ensure coordination of efforts to identify, 
        disseminate, and evaluate best practices related to--
                    (A) improving the capacity of, and access to, 
                recovery support services; and
                    (B) supporting the training, education, 
                professional development, and retention of peer support 
                specialists.
    (c) Report.--Not later than 4 years after the date of enactment of 
this Act, the Assistant Secretary for Mental Health and Substance Use 
shall submit to the Committee on Health, Education, Labor, and Pensions 
of the Senate and the Committee on Energy and Commerce of the House of 
Representatives a report on the activities conducted by the Office, 
including--
            (1) a description of the specific roles and 
        responsibilities of the Office;
            (2) a description of the relationship between the Office 
        and other relevant components or programs of the Substance 
        Abuse and Mental Health Services Administration;
            (3) the identification of any gaps in the activities of the 
        Substance Abuse and Mental Health Services Administration or 
        challenges in coordination between the Office and such relevant 
        components or programs of such agency; and
            (4) recommendations related to the continued operations of 
        the Office.

SEC. 308. REVIEW OF GRANTS.GOV.

    (a) In General.--Not later than 1 year after the date of enactment 
of this Act, the Secretary of Health and Human Services (referred to in 
this section as the ``Secretary'') shall convene a public meeting for 
purposes of improving awareness of, and access to, information related 
to current and future Federal funding opportunities, including Federal 
funding opportunities related to mental health and substance use 
disorder programs.
    (b) Topics.--The public meeting under subsection (a) shall 
include--
            (1) opportunities to improve the utility and functionality 
        of relevant internet websites maintained by the Secretary, such 
        as Grants.gov;
            (2) other models for displaying and disseminating 
        information related to Federal funding opportunities, such as 
        interactive dashboards; and
            (3) strategies to improve the ability of entities to apply 
        for Federal funding opportunities, including entities that have 
        not traditionally applied for programs administered by the 
        Secretary.
    (c) Website Improvements.--The Secretary shall implement 
improvements to Grants.gov based on stakeholder feedback received at 
the public meeting under subsection (a).
    (d) Report.--Not later than 1 year after the date on which the 
public meeting under subsection (a) is convened, the Secretary shall 
submit to the Committee on Health, Education, Labor, and Pensions of 
the Senate and the Committee on Energy and Commerce of the House of 
Representatives a report summarizing the findings of such meeting, 
including how the Secretary has taken into account the feedback 
received through such meeting and implemented improvements to relevant 
internet websites maintained by the Secretary and strategies to improve 
awareness of Federal funding opportunities.

                     TITLE IV--TECHNICAL AMENDMENTS

SEC. 401. DELIVERY OF A CONTROLLED SUBSTANCE BY A PHARMACY TO AN 
              ADMINISTERING PRACTITIONER.

    Section 309A(a) of the Controlled Substances Act (21 U.S.C. 
829a(a)) is amended by striking paragraph (2) and inserting the 
following:
            ``(2) the controlled substance is a drug in schedule III, 
        IV, or V to be administered--
                    ``(A) by injection or implantation for the purpose 
                of maintenance or detoxification treatment; or
                    ``(B) intranasally, subject to risk evaluation and 
                mitigation strategy pursuant to section 505-1 of the 
                Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355-1), 
                with post-administration monitoring by a health care 
                professional;''.

SEC. 402. TECHNICAL CORRECTION ON CONTROLLED SUBSTANCES DISPENSING.

    Effective as if included in the enactment of Public Law 117-328--
            (1) section 1252(a) of division FF of Public Law 117-328 
        (136 Stat. 5681) is amended, in the matter being inserted into 
        section 302(e) of the Controlled Substances Act, by striking 
        ``303(g)'' and inserting ``303(h)'';
            (2) section 1262 of division FF of Public Law 117-328 (136 
        Stat. 5681) is amended--
                    (A) in subsection (a)--
                            (i) in the matter preceding paragraph (1), 
                        by striking ``303(g)'' and inserting 
                        ``303(h)'';
                            (ii) in the matter being stricken by 
                        subsection (a)(2), by striking ``(g)(1)'' and 
                        inserting ``(h)(1)''; and
                            (iii) in the matter being inserted by 
                        subsection (a)(2), by striking ``(g) 
                        Practitioners'' and inserting ``(h) 
                        Practitioners''; and
                    (B) in subsection (b)--
                            (i) in the matter being stricken by 
                        paragraph (1), by striking ``303(g)(1)'' and 
                        inserting ``303(h)(1)'';
                            (ii) in the matter being inserted by 
                        paragraph (1), by striking ``303(g)'' and 
                        inserting ``303(h)'';
                            (iii) in the matter being stricken by 
                        paragraph (2)(A), by striking ``303(g)(2)'' and 
                        inserting ``303(h)(2)'';
                            (iv) in the matter being stricken by 
                        paragraph (3), by striking ``303(g)(2)(B)'' and 
                        inserting ``303(h)(2)(B)'';
                            (v) in the matter being stricken by 
                        paragraph (5), by striking ``303(g)'' and 
                        inserting ``303(h)''; and
                            (vi) in the matter being stricken by 
                        paragraph (6), by striking ``303(g)'' and 
                        inserting ``303(h)''; and
            (3) section 1263(b) of division FF of Public Law 117-328 
        (136 Stat. 5685) is amended--
                    (A) by striking ``303(g)(2)'' and inserting 
                ``303(h)(2)''; and
                    (B) by striking ``(21 U.S.C. 823(g)(2))'' and 
                inserting ``(21 U.S.C. 823(h)(2))''.

SEC. 403. REQUIRED TRAINING FOR PRESCRIBERS OF CONTROLLED SUBSTANCES.

    (a) In General.--Section 303 of the Controlled Substances Act (21 
U.S.C. 823) is amended--
            (1) by redesignating the second subsection designated as 
        subsection (l) as subsection (m); and
            (2) in subsection (m)(1), as so redesignated--
                    (A) in subparagraph (A)--
                            (i) in clause (iv)--
                                    (I) in subclause (I)--
                                            (aa) by inserting ``the 
                                        American Academy of Family 
                                        Physicians, the American 
                                        Podiatric Medical Association, 
                                        the Academy of General 
                                        Dentistry, the American 
                                        Optometric Association,'' 
                                        before ``or any other 
                                        organization'';
                                            (bb) by striking ``or the 
                                        Commission'' and inserting 
                                        ``the Commission''; and
                                            (cc) by inserting ``, or 
                                        the Council on Podiatric 
                                        Medical Education'' before the 
                                        semicolon at the end; and
                                    (II) in subclause (III), by 
                                inserting ``or the American Academy of 
                                Family Physicians'' after 
                                ``Association''; and
                            (ii) in clause (v), in the matter preceding 
                        subclause (I)--
                                    (I) by striking ``osteopathic 
                                medicine, dental surgery'' and 
                                inserting ``osteopathic medicine, 
                                podiatric medicine, dental surgery''; 
                                and
                                    (II) by striking ``or dental 
                                medicine curriculum'' and inserting 
                                ``or dental or podiatric medicine 
                                curriculum''; and
                    (B) in subparagraph (B)--
                            (i) in clause (i)--
                                    (I) by inserting ``the American 
                                Pharmacists Association, the 
                                Accreditation Council on Pharmacy 
                                Education, the American Psychiatric 
                                Nurses Association, the American 
                                Academy of Nursing, the American 
                                Academy of Family Physicians,'' before 
                                ``or any other organization''; and
                                    (II) by inserting ``, the American 
                                Academy of Family Physicians,'' before 
                                ``or the Accreditation Council''; and
                            (ii) in clause (ii)--
                                    (I) by striking ``or accredited 
                                school'' and inserting ``, an 
                                accredited school''; and
                                    (II) by inserting ``, or an 
                                accredited school of pharmacy'' before 
                                ``in the United States''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
take effect as if enacted on December 29, 2022.
                                                       Calendar No. 319

118th CONGRESS

  2d Session

                                S. 3393

_______________________________________________________________________

                                 A BILL

 To reauthorize the SUPPORT for Patients and Communities Act, and for 
                            other purposes.

_______________________________________________________________________

                            February 1, 2024

                       Reported with an amendment
```